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NOTES
PHARMACEUTICAL DISPENSING IN THE "WILD WEST":
ADVANCING HEALTH CARE AND PROTECTING CONSUMERS
THROUGH THE REGULATION OF ONLINE PHARMACIES
The "explosion"1 of Internet pharmacies2 on the World Wide Web
has created a wealth of opportunities for improvements in the
provision of health care? Unfortunately, the Internet's inherent
characteristics that enable these positive developments also provide
fertile soil for modern day "snake oil salesmen"4 and "unscrupulous
marketers.'" Problems such as assuring the quality of medical care,
guaranteeing the accuracy of exchanged information, fraud, and
abuse have rapidly become evident.? While pharmaceutical
dispensing through traditional pharmacies is highly regulated,
guidance concerning the regulation of dispensing on the Internet is
lacking. The market's swift emergence, the unique jurisdictional
elements of its operation, and the diversity of involved governing
bodies have regulators struggling to devise the ideal mechanism to
address the challenge.7
1. See Stephen C. Burson, The Explosion oflnternetPharmacies, PHARACIsTsS LLvm
(Therapeutic Research Center, Stockton, Cal., Oct. 1999).
2. Pharmacies that offer services on the World Wide Web are referred to by many
names, including: Internet pharmacies, online pharmacies, e-pharmacies, and cyber-
pharmacies. For the purposes of this Note, these terms will be used interchangeably.
3. See infra notes 46-53 and accompanying text.
4. Robin Herman,Drugstore on the Net: It's Quick, It's Convenient and It's Unregulated.
Consumers Run the Risk of Harm With Do-It-Yourself Prescriptions, WASH. POST, May 4,
1999, at Z14.
5. See Jane E. Brody, On-Line Health Care for the Savvy Surfer, N.Y. TIMES, Aug. 31,
1999, at F6.
6. See infra notes 67-99 and accompanying text.
7. See Sheryl Gay Stolberg, Internet Prescriptions Boom in the 'Wild West of the Web,
N.Y. TIES, June 27, 1999, at Al.
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Historically, pharmaceutical services have been governed
predominantly by the states. In this respect, a number of states'
attorneys general and state licensing boards have prosecuted online
pharmacy offenders under existing state pharmacy, consumer
protection, and unprofessional conduct regulations.' Alternatively,
a few states have passed new laws dealing explicitly with online
pharmacies.9 On the prosecutorial side, the Food and Drug
Administration (FDA) has also joined the states in a limited role as
provided by the Food, Drug, and Cosmetic (FD&C) Act.' In
addition, the American Medical Association (AMA) and the
National Association of Boards of Pharmacy (NABP) have taken an
active role by respectively formulating recommendations and
instituting a certification program for online pharmacies. 11
Concomitantly, Congress has requested information and heard
testimony concerning online pharmacies. 2 As a result, Congress is
currently considering the implementation of the Internet Pharmacy
Consumer Protection Act as an amendment to the FD&C Act to
provide minimum standards for online pharmacy websites.'3
This Note explores the regulatory challenges of providing
pharmaceutical products via the Internet in the United States. It
begins with a review of the existing regulatory scheme for
prescription drugs in the United States as well as the development
of online pharmacies. It then examines the unique jurisdictional,
public safety, and abuse issues associated with Internet dispensing,
and reviews the applicable legislative history to provide a grounded
understanding of the subject. Following a discussion of the actions
of state and federal regulators, legislators, and health care
professionals, the Note analyzes their respective approaches.
Finally, it recommends a collaborative approach, describing specific
steps for each interested party, that attempts to protect the rights
of legitimate providers while reducing the risks posed by
disreputable operators.
8. See infra notes 193-207 and accompanying text.
9. See infra notes 213-18 and accompanying text.
10. 21 U.S.C. § 301 (1994 & Supp. M 1997).
11. See infra notes 225-41 and accompanying text.
12. See infra notes 122-46 and accompanying text.
13. See infra notes 156-62 and accompanying text.
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THE REGULATION OF PRESCRIPTION DRUGS IN THE UNITED STATES
The Pre-E Era
Traditionally, the states have regulated the dispensing of
prescription drugs. 4 In addition to the practical regulations
regarding dispensing, 5 state pharmacy and medical boards regulate
the licensing 6 and professional standards 7 of health care
practitioners. The decision to defer responsibility for pharmacy
regulation to the states stems from principles elucidated in the
Constitution.18 In particular, the Tenth Amendment preserves the
power of the states to regulate what is not directly regulated by the
federal government. 9 The states, however, are not the sole arbiters
of pharmaceutical law.
The Commerce Clause of the Constitution enables Congress to
regulate commerce among the states.20 With this in mind, the
Federal FD&C Act was enacted in 1938 to control the sale of drugs
and authorize only those that are safe and effective. 2' These
provisions were devised well before the advent of the Internet,
although their purpose was akin to the desires of current
14. See Rita Rubin, Easier-to.Swallow Way to Get YourPills Refilled: E-pharmacies Offer
Convenience ButRaise Safety Concerns, USATODAY, Oct. 6,1999, at 1D; see, e.g., N.J. STAT.
ANN. §§ 45:14-1 to -36.4 (West 1995 & Supp. 2000) (providing New Jersey's regulations for
the practice of pharmacy); VA. CODE ANN. §§ 54.1-3300 to -3319 (Michie 1998 & Supp. 2000)
(providing Virginia's pharmacy provisions).
15. See, e.g., N.J. STAT. ANN. § 45:14-14.4 (West Supp. 2000) (prohibiting pharmacists
from filling a prescription not issued on a New Jersey prescription blank or lacking required
prescriber/facility information); VA. CODE ANN. § 54.1-3410 (Michie 1998) (describing
requirements for a licensed pharmacist to legally sell and dispense a drug).
16. See, e.g., N.J. STAT. ANN. §§ 45:9-6 (requiring a license to practice medicine or
surgery), :14-6 (requiring pharmacists be registered to practice) (West 1995); VA. CODE ANN.
§§ 54.1-2900 to -2910.1, -2929 to -2957.3, -3304, -3304.1, -3310 to -3319 (Michie 1998 & Supp.
2000) (presenting general and specific provisions dealing with various aspects of licensing
health care professionals, including pharmacists and physicians).
17. See, e.g., VA. CODE ANN. §§ 54.1-2914,-3315 (Michie 1998) (describing actions deemed
unprofessional conduct).
18. See U.S. CONST. amend. Y.
19. "The powers not delegated to the United States by the Constitution, nor prohibited
by it to the States, are reserved to the States respectively, or to the people." Id.
20. "The Congress shall have Power... [t]o regulate Commerce... among the several
States. .. ." U.S. CONST. art. I, § 8, cls. 1, 3.
21. See Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301-395 (1994 & Supp. III
1997).
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regulators: "to protect patients from injuries resulting from unsafe
and counterfeit drugs and from illicit practice of medicine and
pharmacy."22 While there may be an inherent assumption, given its
name, that the FDA is the sole authority for the enforcement of food
and drug issues, at least two other agencies wield significant
influence in this arena. The Drug Enforcement Administration
(DEA) regulates narcotic substances via the Controlled Substances
Act,23 and the Federal Trade Commission (FTC) governs the
advertising of over-the-counter medications.2' The requirements of
this integrated system of regulations and authorities at the state
and federal level have provided "an effective safety net to protect
the U.S. public from harmful or ineffective drugs, as well as
improper prescribing or dispensing of pharmaceuticals."25 The
development of online pharmacies, however, has torn a significant
hole in this net.
The Internet & Online Pharmacies
The Internet has evolved into a remarkable tool for acquiring
information (including health care information)26 and conducting
business. A recent Harris Poll indicated that of the 97 million
people using the Internet, 74% view health information.27 While
such access is a hallmark of the Internet and has the obvious
22. Jane E. Henney et al., Internet Purchase of Prescription Drugs: Buyer Beware, 131
ANNALS OF INTERNAL MED. 861, 861 (1999).
23. 21 U.S.C. §§ 801-971 (1994 & Supp. III 1997).
24. See 15 U.S.C. §§ 41, 52-55 (1994); see also Kristen Green, Marketing Health Care
Products on the Internet: A Proposal for Updated Federal Regulations, 24 AM. J.L. & MED.
365,377 & n.72 (1998) (highlighting the role of the FTC in regulating the advertising of food,
drugs, and medical supplies).
25. Henney, supra note 22, at 861.
26. Forty-three percent of online users view healthinformation annually. SeeDrugstores
on the Net: The Benefits and Risks of On-line Pharmacies: Hearing Before Subcomm. on
Oversight and Investigations of the House Comm. on Commerce, 106th Cong. (1999)
(statement by Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research,
FDA) [hereinafter Woodcock], available in 1999 WL 568646 (F.D.C.H.) (citing Investor's
Business Daily). The number accessing this information is growing by 70% annually. See id.
(citing a study by Cyber Dialogue Inc.).
27. See Online Health: Number of Users Continues to Grow, AM. HEALTH LINE, Aug. 5,
1999, available in LEXIS, News Library, Medical and Health Materials Combined.
Additionally, the number of Americans using the Internet for health information, roughly
70 million, increased 16% over seven months. See id,
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advantage of empowering its users, the lack of quality control
standards and the fact that practically anyone can post information
renders the quality of this information particularly suspect.29 As the
editors of the Journal of the American Medical Association
described, "[tihe problem is not too little information but too much,
vast chunks of it incomplete, misleading, or inaccurate." 0 Although
the dangers of incomplete, misleading, or inaccurate information
are not only applicable to online pharmacies,"' the impact of such
information is increasingly pronounced, given the recent surge of
online pharmacies.
According to Carmen Catizone, Executive Director of the NABP,
online pharmacies were among the first e-commerce children of the
New Year, born in earnest following the performances of online
giants such as Amazon.com during the December 1998 holiday
season.12 At that time approximately twenty-six online pharmacies
were identified.3 This number skyrocketed to over 400 by August
28. Brody remarks about two cases of individuals finding legitimate solutions to
individual health ailments that had gone previously uncured. See Brody, supra note 5; see
also Jeanne Lee, The Internet Can Save Your Life;... If it Doesn't Scare You, Mislead You
or Rip You Off First: Here's How to Get the Best Health Info on the Web, MONEY, Mar. 2000,
at 118, 122 (describing one patient's use of the Internet, including professional search
companies, to aid in the diagnosis and treatment of her rapidly deteriorating eyesight).
29. See J. Sybil Biermann et al., Evaluation of Cancer Information on the Internet, 86
CANCER 381,385 (1999).
30. Brody, supra note 5.
31. See Karen J. Bannan, Editorial Content on Drugstore Sites Draws Questions, N.Y.
TIMES (CYBERTIMES), Jan. 14, 2000, available at httpi/www.nytimes.com (questioning the
volume, accuracy, and conflicting interests of medical information provided by online
pharmacies, especially when presented in close proximity to commercial links enabling
consumers to purchase related products).
32. See Shari Roan, YourFriendlyNeighborhoodE-Drugstore, L.A. TIMES, Sept. 20,1999,
at S1.
33. See William Glanz, FDA Warns Against Cyber.drugs: Agency Vows to More Closely
Scrutinize On-line Pharmacies, WASH. TIMES, July 31,1999, at C7; Online Pharmacies:Feds
Push For More Regulation, AM. HEALTH LINE, Aug. 2, 1999, available in LEXIS, News
Library, Medical and Health Materials [hereinafter Online Pharmacies]. Soma.com, taken
from the Greek "for the body," was perhaps the first Internet pharmacy appearing in the
middle ofJanuary 1999. Soma.com is Dedicated to Improving Patients'Health,' CHAIN DRUG
REv., Apr. 26,1999, at 46, LEXIS, News Library, Medical and Health Materials Combined.
In the process Somacom marketed itself as "a retail pharmacy first and foremost,"
attempting to distinguish itself by offering only health care products, avoiding cosmetics and
beauty aids, and attempting to establish a respected reputation as a retail pharmacy, thus
foreshadowing the concerns of patients, practitioners, and regulators. Id. At that time
planetRx.com and Drugstore.com had also announced plans to launch before the end of
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1999. 4 Given the potential financial stakes 5 in this emerging
market, one author remarked, "the battle for customers could make
the online bookstore competition look like a playground scuffle." 6
While Peter Neupert, the CEO of drugstore.com, doubts that
online pharmacies signal the end for traditional drugstores, he
predicts that within five years they will capture 20% to 25% of the
pharmaceutical market." Many of the traditional "brick and
mortar" 8 chain drugstores have launched or invested in existing
March 1999. See Bob Tedeschi, Want to Be an OnlineDrugstore? Take aNumber, N.Y. TImEs
(GYBERTIMES), available at http://www.nytimes.com (Feb. 2, 1999).
34. See Online Pharmacies, supra note 33; Roan, supra note 32.
35. While approximately $165 billion was spent on pharmaceuticals in 1998, including
prescriptions, over-the-counter products, personal care items, vitamins, "wellness' products,"
beauty aids, and cosmetics, see Tedeschi, supra note 33, Forrester Research anticipates that
Internet prescription sales will exceed 15 billion dollars by 2004; see Steve Tarter,
Pharmacies Must Change to Adjust to New Internet Customers, J. STAR (Peoria, IL), Mar. 21,
2000, available in 2000 WL 16487878. If Wall Street is any indicator, however, all of the
existing online pharmacies may not be around in 2004 to enjoy the potential financial
rewards. See Associated Press, Tough Times for Online DrugStores, June 24,2000, available
at http'J/www.nytimes.com (hypothesizing thatplanetRx.com's financial woes are due in part
to its lack of affiliation with a traditional "brick and mortar" provider, and describing the
precipitous drop in stock prices experienced by planetRxcom and Drugstore.com); Sam Howe
Verhovek, Dot-Corn Leaders Await a Shakeout of Losers, N.Y. TIMES, Apr. 23, 2000, at A12
(describingdrugstore.com's focus on customer retention as the company anticipates amarket
shakeout that "'will separate the men from the boys'").
36. Tedeschi, supra note 33. Americans spent roughly five times the amount of money
on prescriptions compared to the U.S. book market. Depending on the source, the number
ranges from $90 billion to $120 billion. Compare Susan Ferraro, Pharmacy Futures, Our
Online Drugstore Test-Drive Found Them Virtually Useless-ForNow, DAILYNEws, Apr. 11,
1999, at 16 (indicating the expenditure was $102 billion), with Tedeschi, supra note 33
(indicating the expenditure for prescriptions alone was $90 billion). See also Herman, supra
note 4 (noting predictions by health industry professionals that Internet pharmacy sales may
compare with the success of Internet music and book sales).
37. See Rubin, supra note 14. It is unclear, however, if such predictions are the chicken
or the egg. In other words, have the potential financial gains in online pharmacy enticed the
entry of the traditional chain drugstore leaders, or is their current presence in the online
market the reason why online industry executives such as Neupert are making such
predictions? Cf Online Pharmacies Convene Summit, Vow to Stop Fraudulent Pharmacy Web
Sites, BNA HEALTH L. REP., Nov. 18, 1999, at 1829, available in LEXIS, Area of Law-By
Topic, Healthcare & Medical (citing a Corporate Research Group report predicting online
pharmacies will obtain one to two percent of the market by 2001).
38. Harris Fleming, Jr., Merck-Medco Separates Mail Service From On-line Pharmacy,
DRUG TopIcs, May 3, 1999, at 51, available in, LEXIS, News Library, Medical and Health
Materials Combined.
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online pharmaceutical services. 9 While some are unconvinced of the
financial rewards of online services,4" many participants have
forged real alliances in the virtual world in an effort to gain access
to pharmacy benefit plan members41 and a broad range of insurance
39. CVS purchased Soma.com in May 1999 for $30 million, and Rite Aid is a significant
investor in Drugstore.com. See Brandon Copple, The Reluctant Webster, FORBES, Oct. 18,
1999, at 78. Others such as Drug Emporium and AARP Pharmacy Service also offer online
prescription services. See The Ins and Outs of Online Drugstores, CONSUMERREP., Oct. 1999,
at 42.
40. A large factor in Walgreen's success is convenience, and not the type offered in a
cyberpharmacy. Perhaps considerations such as this caused Walgreen's Chairman, Daniel
Jorndt to remark, "We're not sure dot.com pharmacies will ever make money.- Copple,
supra note 39; see also Finding the Proper Balance Between Stores and the Net, CHAIN DRUG
REv., Aug. 30, 1999, at RX70, available in LEXIS, News Library, Medical and Health
Materials Combined (highlighting a Jupiter Communications Report predicting that online
purchasing will produce only an incremental business of roughly four percent by 2002). In
other words, traditional brick and mortar pharmacies need to be more concerned with
preventing the loss of customers to online providers than with increasing revenues through
Internet sales.
41. "The real key to the rise of online drug stores will be the participation of pharmacy
benefits managers who handle about 85 percent of the prescription medication consumed by
the nation's insured." Tarter, supra note 35 (quoting a Forrester Research analyst). Merck
& Co., the nation's largest pharmacy benefit manager, and CVS, the nation's second largest
retail pharmacy chain, agreed to connect their Internet sites. See Robert Berner, Merck, CVS
Agree to Link Internet Sites, WALL ST. J., Oct. 6, 1999, at A3. As a result, CVS agreed to sell
the roughly 7000 over-the-counter products that it offers on its own website on an Internet
site run by Merck-Medco and Merck-Medco will permit its members to obtain prescriptions
via CVS's website. See id. Online pharmacies experienced problems when the pharmacy
benefit managers (PBM) they contracted with began canceling their contracts. As a result,
many became allied with major retail chain pharmacies or PBMs. See Burson, supra note 1.
A component of the partnership between Rite Aids purchase of twenty-five percent of
drugstore.com was drugstore.com's access to the participants in Rite Aid's pharmacy benefit
management business. See Nancy Tarleton Landis, Express Scripts, PlanetRx.com Forge
Agreement, 56 AM. J. HEALTH-SYS. PHARMACY 1918 (1999); Berner, supra at A3. Until
recently Rite Aid was the parent company of PCS, the second largest pharmacy benefit
manager in the U.S. See Landis, supra at 1918. However, Rite Aid agreed to sell PCS to
Advance Paradigm Inc. for $1 billion. See Lorraine Mirabella, Rite AidReports WiderLosses,
BALTIMORE SUN, Oct. 11, 2000, at Business, 1C, available in LEXIS, News Library, News
Group File. PlanetRx.com and Express Scripts, the third largest pharmacy benefit manager
in the United States, reached an agreement identifying planetRx.com as the sole Internet
pharmacy to provide prescription and nonprescription products to Express Scripts members.
See id. This agreement was later restructured making planetRx.com the "preferred, but not
exclusive, on line pharmacy" for Express Scripts. News Briefs, 57 AM. J. HEALTH-SYS.
PHARMACY 1479 (2000). As a result of the aforementioned agreements, the three largest
pharmacybenefit managers have secured agreements to provide their customers with online
pharmaceutical services accounting for approximately 137 million Americans. See id.
(referring to 36 million members); Berner, supra, at A3 (referring to links with nearly 51
million Americans); PCS Health Systems, Information Center, Facts and Figures, at
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providers.42 Even with the trepidation of some large chain
pharmacies, however, some smaller family-owned pharmacies that
have been on the decline in recent years' view the online pharmacy
as an opportunity to expand and compete more effectively." An
improved ability to compete may be crucial in an environment in
which perhaps the only thing declining faster than the number of
independent pharmacies is the rate of reimbursement offered by
third-party payors.4 5 Although the experts disagree whether online
pharmacies will be a boon for independents, it will likely be
beneficial for consumers.46 The nature of the Internet clearly offers
some distinct advantages, including additional opportunities for
convenient, discrete, quality, cost-effective pharmaceutical
services.' 7
The beneficial potential of online pharmacies is significant.
Consider the ability to provide information and products to
individuals whose access to conventional pharmacies is restricted
because of chronic disease or geography.48 Similarly, legitimate
http//www.pcshs.com/info/facts.html (last visited Aug. 18,2000) (listing the number of plan
members as fifty million). Obviously the financial potential is significant.
42. "These alliances give the online pharmacies access to almost every major insurance
plan." Burson, supra note 1. For example, Soma.com went from having 300 participating
insurance plans to nearly 9000 after aligning with CVS. See id. While the startup electronic
pharmacies are attempting to obtain contracts with insurance providers, the existing
traditional chain pharmacies have benefited from not having to acquire, but merely extend,
their current insurance contracts to address online sales. See Roan, supra note 32; see also
Ferraro, supra note 36 (discussing some of the "glitches" associated with using an online
pharmacy, including problems associated with insurance coverage).
43. But see Mike Vogel, Independent Pharmacies Rebound, CHAIN DRUG REV., Nov. 22,
1999, at 3, available in LEXIS, News Library, Medical and Health Materials Combined
(emphasizing that although borderline independent pharmacies are gone, the remaining
independents are benefitting from increasing prescription volume and sales).
44. Mom-and-pop drugstores like Giannotto's Pharmacy have established their own web
pages. See Rubin, supra note 37. In addition, CornerDrugstore.com has registered over 1000
independent pharmacies in the United States for patients to obtain online pharmaceutical
services. See id. However, not all of the experts agree that online dispensing will benefit
independent pharmacists. The loss of impulse buying may have a detrimental effect. See id.
45. See Prospects for Drug Chains Bullish, CHAIN DRUG REV., Apr. 26, 1999, at 96,
available in LEXIS, News Library, Medical and Health Materials Combined.
46. See Roan, supra note 32.
47. See id. Additionally, cyberpharmacies often provide such incentives as access to
volumes of reputable health information, such as that offered on the website originated by
former Surgeon General Dr. C. Everett Koop, drkoop.com. They also provide twenty-four-
hour online consultation, and email reminders for refills. See id.
48. See Woodcock, supra note 26.
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options include online prescription transmission," electronic
refills,50  and electronic consults within narrowly defined
circumstances. 5' Essentially, online pharmacies, when coupled with
legitimate practices, "'are just another channel of distribution that
some people will find more convenient,' according to Dr. John L.
Colaizzi, Dean of Rutgers College of Pharmacy. 2 Such benefits are
not limited to online pharmacies; technology is also arriving that
will improve health care delivery between diverse health care
providers and information systems.'
49. Experts believe online prescribing linked -with a bonafide physician-patient
relationship may reduce potential errors associated with handwritten prescriptions. See
Drugstores on the Net: The Benefits and Risks of On-line Pharmacies: Hearing Before the
Subcomm. on Oversight and Investigations of the House Comm. on Commerce, 106th Cong.
(1999) (statement by Herman I. Abromowitz, M.D., American Medical Association),
[hereinafter Abromowitz], available in 1999 WL 568648 (F.D.C.H.); see also Liz Parks,
Electronic Prescribing: The Way of Pharmacy's Future, DRUG STORE NEws, Mar. 6,2000, at
25, available in LEXIS, News Library, Medical and Health Materials Combined (predicting
that ten percent of prescriptions will be transmitted electronically by 2001 because the
'benefits are so real and so great"). Although some brick and mortar pharmacies have
accepted electronic prescriptions for years, planetRxrcom became the first online pharmacy
to dispense an electronic prescription that met the National Council for Prescription Drug
Program's Scriptstandards inJanuary2000. See id. Otherswillikelyfollow. SeeMicroMed
Announces Agreement with Drugstore.com; Successfully Completes RxML Certification
Program, BUS. WIRE, June 15, 2000, available in LEXIS, News Library File (describing the
efforts of Drugstore.com). The rise in electronic prescribing will likely be furthered by the
introduction of wireless, electronic, hand-held prescribing products. See Aetna U.S.
Healthcare* Empowers Physicians With Point-of-Care Information Through Allscripts'
Touchscript Personal Prescriberrm; Enhanced Access to Information Will Help Physicians
Reduce Medication Errors, PRNEWsWIRE, June 8,2000, available in LEXIS, News Library,
News Group File [hereinafter Aetna].
50. See Aetna, supra note 49.
51. Such circumstances may occur when the physician has the patientes medical history
and physical information, has seen the patient recently, and the patient is under the
physician's care. See id.; cf AMA Promotes E-Mail in Physician-Patient Communications
with Suggested Guidelines, BNAHMALTHL. REP., June 22,2000, at 956, available in LEXIS,
Area ofLaw-ByTopic, Healthcare & Medical (discussing the adoption ofemail guidelines for
patient communication and the adoption of a proposal recommending reimbursement for
such electronic communications).
52. Robert Cohen, Regulation of Drugs on the Web: Authorities Struggle to Rein in
Business, STAR-LEDGER (Newark, N.J.), July 6, 1999, at 1. (describing legitimate practices
as the existence of "a physician-patientrelationship," meetingof "ethical considerations," and
the following of "standard practices").
53. See Burson, supra note 1 (describing the Windows DNA system as a "portal" for
health care providers to access patient information); MicrosoftAnnounces Windows DNAfor
Healthare During Annual Microsoft Healthcare Users Group Conference, at http/Ywww.
microsoft.com/PressPass/press/1999/sept99/windnapr.asp (Sept. 15, 1999).
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The potential advantages of online pharmacies, however, do not
exist in a vacuum. They are accompanied by a longer, and
potentially more detrimental, list of disadvantages, including:
concerns about privacy and the transmission of confidential health
information;' difficulties with insurance coverage;55 length of time
associated with the process;56 added costs;57 lack of opportunities for
personal uniform contact" and counseling;59 opportunities for fraud
and abuse;6" and the added competition from traditional pharmacies
implementing more modern conveniences.6 " Additionally, a
particular challenge may rest in certain patients themselves.
Although older individuals are typically the largest users of
54. See Cassie M. Chew, Industry Asks: Can HHS Rule Protect Privacy, Promote E-
Commerce?, BNA HEALTH L. REP. Mar. 30, 2000, at 486 (expressing the concern of the
Department of Health and Human Services that the "risk of improper uses and disclosures
has increased as the health care industry has begun to move from primarily paper-based
information systems to systems that operate in various electronic forms). Such concerns
may be addressed by services such as the online credentialing of physicians, recently
announced by Intel Corp. and the American Medical Association. See Ann Carrns, Intel and
AMA Form Service to Improve Security of Online Medical Information, WALLST. J., Oct. 12,
1999, at B6.
55. See Sharon Bernstein, Ordering Drugs Online Can Still Be a Headache, L.A. TIMES,
Sept. 30, 1999, at C9 (stating that online pharmacies are grappling with "the clunky process
of taking orders, verifying insurance and prescription authenticity and delivering the
product").
56. Patients may expect standard delivery in five to ten days, and some deliveries
deemed "overnight" may take two or three days. See The Ins and Outs of Online Drugstores,
supra note 39. These limits may be due in part to the fact that some orders are not processed
on weekends or holidays. See id.
57. Fees may range from free shipping for first-class mail to twenty dollars for overnight
delivery depending upon weight. See id,
58. In a recent survey, 72% of physicians and 76% of pharmacists surveyed believed that
Internet pharmacies would provide additional strain on the pharmacist-patient relationship.
See Val Cardinale, Report Predicts Bright On-line Pharmacy Future, DRuGToPics, June 5,
2000, at 27, available in LEXIS, News Library, Medical and Health Materials Combined.But
see id. (indicating that most consumers did not believe Internet pharmacies would affect
pharmacist-patient relationships).
59. In an era when "pharmaceutical care" is the professional buzzword and pharmacists
are encouraged to develop significant patient relationships, the Internet may provide
communication advantages and new challenges.
60. See infra notes 67-99 and accompanying text.
61. Traditional chain drugstores are implementing new systems such as automated
telephone refills, drive-through pick-ups, and continuing with ordinary, customer-friendly
services, such as home delivery.
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prescription drugs in the United States, 2 and consequently account
for a substantial pool of potential online pharmacy customers, they
also represent a segment of the population less likely to have
Internet access. 3 This level of access, however, may already be
changing."4
In another aspect of the consumer realm, the FDA and
pharmaceutical manufacturers are strugglingwith regulatory65 and
liability66 concerns surrounding the direct-to-consumer promotion
and advertising of pharmaceuticals on the Internet. Even with all
of these considerations, a concern that underlies all Internet
pharmacy transactions, beyond the mere adequacy of information
and accuracy of dispensed products, is the reputability of the
entities' practices. Reputable behavior, or its more troubling
62. "The elderly are the largest consumers of prescription medications... because they
have the lion's share of chronic diseases and symptoms." Ronald B. Stewart,Drug Use in the
Elderly, in THERAPEUTICS IN THE ELDERLY 174 (Jeffrey C. Delafuente & Ronald B. Stewart
eds., 2d ed. 1995).
63. See Rubin, supra note 37. The high incidence of chronic disease in the elderly results
in their significant use of maintenance medications. See Stewart, supra note 62, at 174. As
a result, the regularity and long-term therapy associated with maintenance medications
makes the elderly particularly well suited for online prescribing.
64. The ability ofonline pharmacies to capture this potential market is not without hope
as those over fifty represent the most rapidly growing subgroup in cyberspace. See Rubin,
supra note 37.
65. See Green, supra note 24, at 365; David W. Opderbeck, How Should FDA Regulate
Prescription Drug Promotion on the Internet?, 53 FOOD & DRUG L.J. 47 (1998); Peter S.
Reichertz, Legallssues Concerning thePromotion ofPharmaceuticalProducts on the Internet
to Consumers, 51 FOOD & DRUG L.J. 355 (1996).
66. PlanetRx.com and drugstore.corn have established separate facilities for their
prescription and nonprescription inventoryin part to avoid potential errors in filling patients
orders. See Tedeschi, supra note 33. NotAbly, the New Jersey Supreme Court's holding in
Perez v. Wyeth Labs Inc. marked a shift in manufacturers' potential liability and the
importance of the learned intermediary doctrine. 734 A.2d 1245, 1256 (N.J. 1999) (holding
that the 'learned intermediary" defense is not available to manufacturers who participate
in direct marketing of drugs to consumers). The significance of this holding should not be
taken lightly, especially considering the significant number of pharmaceutical companies
that reside in New Jersey. New Jersey has been referred to as "the nation's medicine chest."'
See Edward R. Silverman, DrugFirms Boost New Jersey's Economy by More than $8 Billion,
STAR-LEflGER (Newark, N.J.), Dec. 14,1997, available in LEXIS, News Library, News Group
File. In addition, it remains to be determined, in light of the New Jersey Supreme Court's
holding, the impact rogue Internet pharmacies' dispensing of products may have on
pharmaceutical manufacturers. Pfizer, the maker ofsildenafil citrate, known under the trade
name Viagra, filed a complaint with the FTC to prohibit the online dispensing of Viagra
without adequate protection. See Roan, supra note 32.
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absence, is at the heart of the debate about online pharmacy
regulations.
Internet Prescribing and Safety
Functionally speaking, reputable online pharmacies do not
operate much differently from their "brick and mortar" 7 brothers
or mail-order 8 sisters. Patients contact the pharmacy via the
Internet, and after providing the necessary registration and
payment information (e.g., name, address, drug allergies, current
medications being used, etc.), the pharmacy dispenses a medication
from a prescription provided via mail, e-mail, phone, or fax,
depending upon the given state's regulations.69 Depending upon the
online pharmacy's parent, the patient may then pick up the
prescription at a locally convenient retail site or have the
prescription delivered via standard or overnight delivery.70 These
legitimate sites, while introducing new practical concerns for
regulators, are not the predominant problem.
The most dangerous and worrisome sites are those rogue
pharmacies that provide patients with prescription medications
over the Internet via online doctors' services with essentially no
examination or physician contact. 1 Consumer demand for these
services is being met by a waiting list of physicians, lured by the
67. Fleming, supra note 38, at 51.
68. Although MerckoMedeo is attempting to distinguish its mail order component from
online pharmacies, it has conceded that it possesses common dispensing interests, and as
such a similar functional framework. See id. Additionally, insurance providers such as Blue
Cross and Blue Shield's Federal Employee Program, which insures 3.7 million patients, are
cautious about the potential impact of online pharmacies on exclusive mail order coverage
options. See Tedeschi, supra note 33.
69. Some states viewed online pharmacies similarly with mail-order ones and licensed
them to dispense in their state. See Burson, supra note 1. Roughly half of the states permit
the electronic transfer of prescriptions. See id.; see also Theodore R. LeBlang, E-mailScripts
Seen AsAnalogous To Phone.Ins, Am. DRUGGIST, Apr. 1,1999, at 54-55 (describing Walgreen
Co. v. Wisconsin Pharmacy Examining B&e, 577 N.W.2d 387 (Wis. Ct. App. 1998), in which
the Wisconsin Court of Appeals noted the benefits of electronic prescribing, indicated the
similarities to traditional methods, and airmed the circuit court's ruling in favor of
Walgreen's use of an electronic prescribing test system).
70. See The Ins and Outs of Online Drugstores, supra note 39.
71. See TheDoctoris Online, InternetPharmaciesAreNoPanacea, COLUMBUSDISPATCH,
Feb. 14, 1999, at 2C, available in LEXIS, News Library, News Group File [hereinafter The
Doctor is Online].
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prospect of easy money, writing prescriptions for existing sites,72 or
by physicians starting their own online dispensary.7 Lack of
adequate physician-patient interaction is only the first problem.
The process of obtaining a prescription through a domestic rogue
online pharmacy illustrates some significant health safety concerns.
Perhaps a telling aspect of the motivation behind these sites is often
the first question they require online patients to answer: Will that
be Visa or American Express?74 Although profitability is an obvious
goal of these sites, consumer safety is the target of regulators.75
Many sites do not list the credentials of health professionals, if any,
who are involved in the process.76 There is often no way, therefore,
to determine the credentials, identity, or even if a pharmacist or
physician is involved. Equally disturbing are the health question-
naires that such sites often use in lieu of a traditional physician
exam." The problems of this pseudo-exam are subsequently
aggravated by the inability for follow-up.78 Overall, these sites do
the absolute minimum in a veiled attempt to comply with state
72. See Stolberg, supra note 7. Struggling physicians, like Dr. Leandro Pasos, sign up
with companies like Performance Drugs to review electronic health forms of potential
Viagrae patients for $5,000 per month. See id. Additionally, Bill Stallknecht, pharmacist and
co-owner of ThePillbox.com, has stated, "I probably have 5,000 names of doctors who want
to participate." Id.
73. See id. According to Eric Thom, Vice President ofConfimed.com, the site was founded
by an obstetrician-gynecologist after he hired a website designer, "called his pharmaceutical
representative, gave them his American Express number, ordered about 200 pills and started
listing his site on some search engines." Id.
74. See Bernard S. Bloom & Ronald C. lannacone, Internet Availability of Prescription
Pharmaceuticals to the Public, 131ANNAISOFINTERNALMED. 830,832(1999). This, however,
is not necessarily different from a patient's experience in a traditional health care setting.
See id. (indicating that most hospitals and physicians' offices request payment information
before medical information).
75. Carmen Catizone, Executive Director of NABP stated, 'We are not concerned about
the economics, but about patient safety.' Lisa Napoli, Dispensing of Drugs on Internet Stirs
Debate, N.Y. TIMES, Apr. 6, 1999, at F6.
76. Dr. Bloom and Mr. lannacone's study determined that although 21.4% of sites
surveyed provided information on how physicians become consultants, at least 80.4% of the
sites surveyed did not provide physicians' names, specialties, locations, or qualifications. See
Bloom & Iannacone, supra note 74, at 831-32.
77. See Randolph D. Smoak, Jr., Internet Prescribing, Report of the Board of Trustees of
the American Medical Association #35-A-99, at http'J/www.araa-assn.org/meetings/publicl
annual99/reports/onsitelbot/rtf/bot35.rtf (last visited Oct. 23, 2000) (discussing the dangers
and inadequacies of the minimal information exchanged via rogue online pharmacy
questionnaires, including a sample questionnaire for Viagra).
78. See id.
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examination and dispensing requirements. 79 These operational
mechanisms, coupled with FDA approvals in recent years of a
number of"lifestyle" 0 drugs like Viagra, have provided illegitimate
sites with a potentially profitable but flagrantly dangerous niche
market.8 " This market often preys on the fears, desires, and wallets
of "cyberchondriacs." 2
As if rogue domestic sites were not dangerous enough, foreign
sites present their own unique and dangerous concerns. The
problem of patients ordering prescription drugs from foreign
countries is not new. According to Bill Hubbard, acting deputy
commissioner for policy with the FDA, "'[w]e've always had these
catalogues where people could buy from overseas, but it was a very
small market.... The Internet takes it up a big notch.'"' Although
pharmaceutical companies may not market unapproved drugs in
the United States, and U.S. Customs or Postal authorities may
seize these products in the mail, individuals may order these drugs
as long as they are for their own use." Although Hubbard is correct,
"big" is probably an insufficient term to describe the magnitude of
the Internet's impact and the plethora of resulting problems. As
Representative Ron Klink (D-Pa.) described, '[i]t is strictly the
Wild West of drug dealing via the Internet.'" 5 The Internet is often
praised for the accessibility it offers to legitimate products and
information; however, the same access enables patients to order
79. See, e.g., Stolberg, supra note 7 (describing the procedures of a Texas online
pharmacy owner who accepts prescriptions only from Texas physicians to reduce the "chance
of running afoul of regulators in another state").
80. Examples of "lifestyle" agents include: sildenafil citrate [(Viagra5 ), for erectile
dysfunction], finasteride [(Propecia) for hair loss], orlistat [(Xenical) for obesity],
levonorgestrel and ethinyl estradiol [(Preven) for emergency contraception], bupropion
hydrochloride [(Zyban) for smoking cessation]. See Roan, supra note 32.
81. See infra notes 74-97 and accompanying text.
82. See Ann Carrns, Cyberchondriacs Get What GoesAround On the Internet Now, WALL
ST. J., Oct. 5, 1999, at Al (describing how the accessibility of health information and the
interactive environment of the Web work to fuel hypochondriacs' anxiety).
83. Herman, supra note 4.
84. See id.; see also 21 U.S.C. § 956 (1994) (indicating the personal use exemption for
controlled substances).
85. Stolberg, supra note 7. But see Sarah E. Taylor & Harold J. Feld, Promoting
Functional Foods and Neutraceuticals on the Internet, 54 FOOD & DRUGL.J. 423,432 (1999)
(commenting that "law applicable in real space is equally applicable in cyberspace, although
the Internet may create challenges for implementation").
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oxycodone from Spain, 6 or Xenical® from the British Channel
Islands."7
Equally troubling is the anonymity that cyberspace provides and
the resulting ability of patients to mistakenly" or deliberately 9
falsify information in order to obtain the approved and unapproved
products they desire. A number of journalists have spotlighted the
dangers in their own purchasing exploits,90 and at least one news
station obtained Viagra for two pets, a deceased person, and a man
with cardiac disease.9 ' Inherent in this acquisition is the ability of
patients to obtain medications "without so much as talking to a
doctor."92 Federal regulations are designed to provide safe and
86. See Napoli, supra note 75 (describing oxycodone as an analgesic classified as a
controlled substance in the United States).
87. See Herman, supra note 4.
88. See Bloom& Iannacone, supra note 74, at 832 (explaining that default click selections
facilitate patients' provision of false information); Smoak, supra note 77 (theorizing that the
medical history questionnaires used by rogue online pharmacies may contain medical
terminology that is "likely to be beyond the level of understanding of a lay person).
89. See Bloom & Iannacone, supra note 74, at 832. For example, there is little barrier to
prevent apatient suffering from an eating disorder from ordering and receiving aweight loss
product designed for the clinically obese. See Joshua Fischman, Drug Bazaar: Getting
Medicine Off the Web is Easy, But Dangerous, U.S. NEWS & WORLD REP., June 21, 1999;
Herman, supra note 4. Physicians and pharmacists participating in these rogue sites defend
their practice by claiming that patients who are prepared to lie will get the drug whether
online or in a traditional setting. See Herman, supra note 4; Napoli, supra note 75. One
physician stated, 'I have to assume you are telling the truth. Even if you come to my office,
you can tell me anything." Stolberg, supra note 7. But see Herman, supra note 4 (arguing
that at least in person, "the doctor can see their approximate age, their obesity, listen to their
heart, take a blood pressure reading").
90. See Liz Brody, Prescription for Tragedy: Just Name the Rx Drug, and You Can Buy
It Online; Online Rx Drugs a Deadly Threat, N.Y. POST, Mar. 12, 2000, at 6, available in
LEXIS, News Library, News Group File (identifying the various products purchased without
a prescription by the health editor of Glamour, including Xenical, Prozac®, Ultram®,
penicillin, Preven, and Xylocaine®); Bernstein, supra note 55; Fischman, supra note 89;
Corey Hann, Viagra Anyone?, U. WIRE (Syracuse), Mar. 30, 2000, available in LEXIS, News
Library, News Group File; The Ins and Outs of Online Drugstores, supra note 39, at 42; Patti
Waldmeir, E-health Practitioners Fell for My Online Deception: Patti Waldmeir on the Ethics
of Web Sales As a Potentially Lethal Drug is Sent to a Fictional Character Whose Only Link
with Reality Was Somebody Else's Credit Card, FIN. TIM (London), June 22, 2000, at 11,
available in LEXIS, News Library, News Group File; Today: Discussion with Janice
Liberman (NBC television broadcast, Mar. 20, 2000), transcript available in LEXIS, News
Library, News Group File.
91. See RonaldM. SchwartzFDA, FTCPromiseActionAgainstInteret Wrongdoers,AM.
DRUGGIST, Sept. 1999, at 11.
92. Fischman, supra note 89.
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efficacious products manufactured under strict quality control
guidelines, but there are no such guarantees with products obtained
through rogue foreign online pharmacies. 3 In fact, there is no
guarantee that the product ordered is the one the patient actually
requested." Additionally, the lack of adequate physical exams and
consultations may increase the risk of potentially life-threatening
drug interactions or harmful adverse events. 5
Beyond the problems resulting from online providers, now
regulators have to contend with electronic bulletin boards enabling
an online "flea market,"" where patients are offering to sell their
leftover drugs to other patients.97 The significance of the problems
with online pharmacies was highlighted by Bloom and Iannacone's
recent study.98 The importance of their results was manifested in
the decision of the editor of the Annals of Internal Medicine to post
the study on its website months before the article was scheduled for
publication.99 As health professionals and probing journalists
expose the intrinsic health related problems of these disreputable
sites, the legislators, regulators, and professional organizations are
also developing a heightened awareness of the thorny jurisdictional
problems inherent in these electronic transactions.
93. See id,
94. See Woodcock, supra note 26.
95. In one instance, a fifty-two-year-old man with a history of cardiac disease died from
a heart attack after purchasing Viagra from an Internet provider that required only the
completion of a questionnaire before shipping the product. Although the drug has not been
linked to his death, the FDA has emphasized that a physician's direct examination could
have prevented the event. See GOOD QUESTION, How Safe is It to Buy Prescription Drugs
Online?, FLA. TIIES-UNION (Jacksonville), May 7, 2000, at H-5; see also Fischman, supra
note 89 (discussing the risks of purchasing drugs online); Andrew Jacobs, 4 New Jersey Prep
Schoolers Fall Ill After Buying Drug on eBay, N.Y. TIMES, May 26, 2000, at BI (describing
the hospitalization of four seventeen-year-old students after overdosing on dextromethorpan
purchased online); Smoak, supra note 77 (indicating that although Viagra is beneficial to
manymen, it also has been linked to 100 deaths); TheDoctor is Online, supra note 71 (noting
that Propecia (for hair loss) may cause birth defects if a pregnant woman touches the
product).
96. Napoli, supra note 75.
97. See id.
98. See Bloom & Iannacone, supra note 74.
99. See id; see also Denise Grady, DrugBuying On the Web?Be Careful, Study Says, N.Y.
TIMES, Oct. 5, 1999, at F7. This early release is an ideal example of the accessibility and
reliability of information that the Internet can provide.
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Jurisdiction and Jell-O®
The problem facing regulators is that a patient may sit at their
home personal computer in one state, deal with an online site in
another state, have a prescription issued by a physician in a third,
and then have a pharmacy in a fourth state dispense the product.10
This intricate web of connections has left lawmakers puzzled,
wondering where to start. The FDA has the authority to act under
the auspices of the FD&C Act.1 Additionally, other federal
agencies, such as the FTC, 02 DEA,103 U.S. Customs Service,0 4 and
the Postal Service, 05 have related authority. Furthermore, the
states regulate the licensing of pharmacists, pharmacies, and other
health professionals.' Although the states lacked explicit
regulations or laws on e-prescribing at the end of 1998,107 some
states' attorneys general have filed claims using existing state
licensing and consumer protection laws.108 Finally, professional
organizations such as the AMA and the NABP provide licensing and
professional standards.' 9 Although each group is an important
member of the enforcement team, their roles and interactions
remain inadequately defined. As James Winn, Executive Vice
100. See Woodcock, supra note 26; see also Minutes-Food & DrugAdministration Office
of Health Affairs Health Professional Organizations Meeting [hereinafter Minutes], at
http-/lwww.fda.gov/ (Feb. 8, 1999) (on file with William and Mary Law Review) (describing
the related experience of Dr. John O'Bannon of the AMA Council for Ethical and Judicial
Affairs).
101. See Woodcock, supra note 26.
102. See 15 U.S.C. §§ 41, 52-55 (1994); see also Green, supra note 24.
103. See 21 U.S.C. § 878 (1994) (describing the powers of enforcement personnel in the
DEA).
104. See 19 U.S.C. § 1589a (1994) (describing the enforcement authority of customs
officers).
105. See 18 U.S.C. § 3061 (indicating the investigative authority of Postal Service
personnel).
106. See supra notes 16-17 and accompanying text.
107. See Smoak, supra note 77.
108. See infra notes 193-207 and accompanying text.
109. See Abromowitz, supra note 49 (discussingthe AMA's opinion on the steps physicians
should take before prescribing medication and minimum standards of medical care); National
Association of Boards of Pharmacy, VIPPS Home Page, at http:/www.nabp.net/vippsrmtro.
asp (last modified Oct. 7, 1999) (stating that the NABP "was established... to assist state
licensingboards in developing, implementing, and enforcinguniform standards to protect the
Public Health!).
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President of the Federation of State Medical Boards (FSMB),
stated, the difficulties inherent in this regulatory scheme are like
"'trying to nail Jell-O to the wall.'""'
The process of bringing an online site or provider to justice is
complicated from the first step, identifying them. Many of the
disreputable sites do not maintain information about their location
or providers, often requiring law enforcement personnel to "'sort
through multiple shell corporations, addresses that turn[] out to be
mail drops, and overlapping physical and Internet addresses shared
by different entities."' 1 Once identified, the enormity of the Web
allows providers to close up shop and re-appear at another site a
short time later.12 The FDA has made efforts both alone and with
the help of Internet Service Providers' (ISPs) to act against these
sites, but it is a formidable task, requiring additional resources."
Although the domestic jurisdictional issues are particularly
daunting, the problem of bringing action against a foreign site is
even more frustrating because jurisdiction is limited."' According
to Carmen Catizone, Executive Director of the NABP, "[tihe foreign-
based sites are going to be almost impossible to monitor." 6 Given
this difficulty, the FDA is working with the World Health
Organization (WHO)"' and cooperating with other nations" 8 in an
110. Rita Rubin, On-line Viagra Worries Medical Boards, USA TODAY, Jan. 21, 1999, at
ID.
111. Associated Press, New Curbs on Internet Pharmacies Sought (May 26, 2000),
available at http'J/www.nytimes.com (quoting Kansas Attorney General Carla J. Stovall).
112. See Schwartz, supra note 91, at 11.
113. See Woodcock, supra note 26 (describingthe FDA's requests forvoluntary cooperation
of website managers to remove illegal sites and ads).
114. See Minutes, supra note 100 (noting the FDA's lack of sufficient resources to combat
the problem on its own).
115. See Hearing Before the Subcomm. on Oversight and Investigations of the House
Comm. on Commerce, 106th Cong. (2000) (statement of William K. Hubbard, Senior
Associate Commissioner for Policy, Planning, and Legislation, FDA) [hereinafter Hubbard],
at http'/www.fda.gov/ola/2000/internetsales.htnal (May 25,2000) (lamenting that although
the FDA has jurisdiction over foreign residents who violate the FD&C Act by selling to U.S.
residents, practical issues prevent enforcement); Woodcock, supra note 26 (highlighting the
limited jurisdiction possessed by federal agencies to deal with foreign online providers).
116. Roan, supra note 32.
117. See Minutes, supra note 100.
118. See Hubbard, supra note 115 (stating that the FDA Office of Criminal Investigations
maintains relationships with Belgium, Brazil, Canada, Germany, Ireland, the Netherlands,
Singapore, Spain, and the United Kingdom, as well as other nations).
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attempt to address the problem, but a formalized international
approach does not yet exist. One reason may be the various
standards for prescription medications throughout the world. 19 In
the meantime, the WHO has stressed cooperation among member
nations to enforce particular national standards and prohibit illegal
international sales." An increasing awareness of the problems
found in a global electronic pharmaceutical market led lawmakers
abroad" and at home to call for action.
Viagra® E-mail and Legislative Impetus
The legislative process officially began in March 1999, when
Democratic members of the House asked the Comptroller General
to conduct a formal review of the "exploding trend of online phar-
macies."12 Ironically, only a few days later, Dennis P. Fitzgibbons,
minority deputy staff director for the House Commerce Committee,
received e-mail messages promoting a website where consumers
could purchase Viagra without a physician's visit." In their letter,
the House members expressed concern that these pharmacies "may
be outpacing formal state and federal controls,"'2 and requested an
119. See Herman, supra note 4.
120. See id.
121. See Kevin O'Sullivan,MedicinesBoard Supports USMoveonfllegal WebPharmacies,
IRISH TIMFs, Dec. 31, 1999, at 4, available in 1999 WL 24436659 (indicating that the Irish
Medicines Board has called for an EU-wide initiative to address online pharmacy issues); see
also Hubbard, supra note 115 (describing an Italian proposal that all of Europe address the
issue); Adam Creed, New Zealand Looks to Close Internet Medicines Loophole, NEWSBYTES,
Jan. 21, 2000, available in 2000 WL 2272221 (relating efforts by the New Zealand Ministry
of Health to eliminate a legal loophole enabling pharmacists to provide prescription drugs
to foreign patients without a prescription); Alex Hannaford, No Prescription Needed: The
Internet Drugs Scam, EVENING STANDARD (London), Mar. 14, 2000, at 60, available in 2000
WL 6858633 (elaborating on a government investigation in the UK focusing on online
pharmacies, particularly DirectResponse Marketing, located in the British Channel Islands).
122. Letter from John D. Dingell et al., Members of the House Committee on Commerce,
to David M. Walker, Comptroller General of the United States [hereinafter Dingell], at
http'/www.house.gov/commercedemocrats/press/1061trl6.htm (Mar. 2, 1999).
123. Although Fitzgibbons did not purchase the medication, the plethora of disclaimers
and liability releases, as well as the speed of the process and limited information exchanged,
suggested to him that "[the] virtual physician [was] a virtual quack.' Suzanne M. Smalley,
Drugs Online: Virus or Cure?, NAT'L J., June 12, 1999, at 1606.
124. Dingell, supra note 122.
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analysis of five primary issues.'25 Shortly after submitting this
letter to the Comptroller, the members also requested the input of
Dr. Jane Henney, Commissioner of the FDA.'26 In their letter to Dr.
Henney, the members requested the FDA's opinion or knowledge on
six primary issues."' In response, the FDA addressed the members'
concerns first in written form,'28 and later in testimony before the
Subcommittee on Oversight and Investigations. 9
In its letter, the FDA specifically responded to the members' six
points in the following ways. First, although the FDA was aware of
the authority of various federal regulatory agencies and states
regarding online pharmacies, it was unaware of any single agency
that functioned as the "primary regulator."3 0 Second, while the
states traditionally regulate dispensing, the FDA's Center for Drug
Evaluation and Research (CDER) reviews and acts against
"violative" sites.'31 Additionally, the FDA's limited authority
(especially regarding foreign sites) and resources necessitate the
surveillance and assistance of multiple federal agencies, state
125. See id. These issues were: (1)How pervasive is the online pharmaceutical industry?
. ."; (2)[D]etermine the differences between [existing] online pharmacies . ... ";
(3)"Determine how these firms are or are not being regulated. ."; (4) "[HIow issues of
health safety and privacy are being addressed"; and (5) "What quality issues pertain to the
methods used to ship these... products?" Id.
126. See Letter from John D. Dingell et al., Members of the House Committee on
Commerce, to Jane E. Henney, M.D., Commissioner of the Food and Drug Administration
[hereinafter Henney], at http/www.house.gov/commercedemocrats/ pressl106/trwe.htm
(Mar. 25, 1999).
127. See i&. These issues were: (1) "What agency... [should be] the primary regulator of
Internet pharmacies?"; (2) "What specific activities or functions does FDA believe it is
responsible for... ?"; (3) Are the existing laws and accompanying regulatory structure
adequate?; (4) "[IThe differences between existing online pharmacies."; (5) How issues of
health, safety, and privacy are being addressed; and (6) "[W]hat quality issues... relate to
the methods used to ship [these] ... products, and does [the] FDA believe it has jurisdiction
in this area?" Id.
128. See Letter from Melinda K. Plaisier, Interim Associate Commissioner for Legislative
Affairs, Food and Drug Administration, to Henry A. Waxman, House Committee on
Commerce [hereinafter Plaisier], at http://www.house.gov/waxman/pdf/5-99onl.pdf (May 7,
1999).
129. See Woodcock, supra note 26.
130. See Plaisier, supra note 128.
131. See id. The FDA's acts have included: sending warning lptters to sites promoting
unapproved agents, sending warning letters to foreign sites with copies to their respective
home governments, posting import alerts on illegal foreign items available via the Internet,
working with Web managers to remove infringing sites, and acting against promotional
claims that violate the FD&C Act. See id.
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boards, and professional organizations.1 12 To this end, the FDAwas
developing draft guidance and assessing its human resources.
33
Third, the FDA's internal working group was planning to meet to
address the adequacy of existing regulations and regulatory
design." Fourth, the FDA expressed concern over the "geographic
diffusion and other unique characteristics of the Internet,""5 and
stated that new regulations must deftly balance the concerns of
legitimate e-commerce with the need to protect public health.136
Fifth, the FDA was unable to assess potential problems with
privacy and the potential for adverse events. 3 Furthermore, the
FDA had no evidence at the moment to indicate that online
pharmacies were more susceptible to fraud than other pharmacies
that lack direct patient contact."' Finally, the FDA asserted that
quality standards apply "to all drugs sold in commerce in the
United States, regardless of whether the order is placed in person,
online or by the mail."139
In contrast to this initial correspondence, the FDA's subsequent
legislative testimony was not designed to answer provided
questions. Instead, the agency focused on the benefits and risks
associated with online pharmacies, framing its initiatives as a
governmental hands-off approach consistent with the
Administration's Framework for Global Electronic Commerce.1 '
Additionally, this initial testimony,141 and the subsequent hearing
132. See id.
133. See id.
134. See id.
135. Id.
136. See id.
137. See id.
138. See id
139. Id.
140. See Woodcock, supra note 26. The five principles of the Framework for Global
Electronic Commerce are:
1. The private sector should lead. 2. Governments should avoid undue
restrictions on electronic commerce. 3. Where governmental involvement is
needed, its aim should be to support and enforce a predictable, minimalist,
consistent and simple legal environment for commerce. 4. Governments should
recognize the unique qualities of the Internet. 5. Electronic Commerce over the
Internet should be facilitated on a global basis.
Id.
141. See id.
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held roughly one year later,'42 informed the Subcommittee about
the FDA's continuing progress in cyberspace.
The FDA was joined by professional organizations such as the
AMA in this democratic process. 43 AMA physician Herman I.
Abromowitz's testimony focused on the physician's professional
perspective toward online prescribing. In particular, Dr.
Abromowitz highlighted the AMA's opinion on the minimum
standards for proper medical care,' the AMA's desire to work
collaboratively with other organizations to facilitate acceptable
electronic prescribing practices, 145 and the opportunities for
legitimate online prescribing.
146
INITIAL RESPONSES TO THE ONLINE PHARMACY PHENOMENON
Federal Enforcement
FDA
The FDA, through its Office of Regulatory Affairs and Center for
Drug Evaluation and Compliance, has actively confronted the
problem of illegal online pharmaceutical sales. It initially identified
over sixty cases potentially linked to such illegal sales." 7 Dr.
Woodcock, Director of the FDA's CDER, identified some prime
examples in her testimony before Congress. 148 These included: (1)
142. See Hubbard, supra note 115.
143. See Abromowitz, supra note 49.
144. These minimum standards include: (1) "an examination of the patient to determine
a specific diagnosis and whether there actuallyis a medical problem;" (2) "a dialogue between
the physician and patient to discuss treatment alternatives and determine the best course
of treatment;" (3) "[the physician must establish or have ready access to a reliable medical
history-," (4) "provid[ing] information to the patient about the benefits and risks of the
prescribed medication;" and (5) "physician . .. follow-up . . . to assess the therapeutic
outcome." Id.
145. See id (expressing the AMA's desire to work with state medical societies, state and
federal regulatory bodies, the Federation of State Medical Boards, and others).
' 146. See id. (identifying three areas that the AMA considers legitimate uses of online
prescribing: "Computer order entry and on-line transmission of prescriptions"; "[oirdering
refills-either patient to pharmacy or physician to pharmacy"; and "[ellectronic consults
between physician and patient where the outcome is an ordered prescription.").
147. See Woodcock, supra note 26.
148. See id.
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the first FDA conviction for wire fraud based on the online sale of
an unapproved HIV home test kit;149 (2) the identification of a
Canadian website that provided GHB prep kits to an Illinois man
who was later convicted of possession of a controlled substance;150
(3) the seizure by the FDA's Office of Criminal Investigations (OCI)
of multiple steroid shipments from foreign manufacturers tc the
operator of a U.S. website that purported to function as a "buyers
club"; 51 and (4) multiple efforts against a South American lab,
marketing via its company website, abortion kits containing
drugs unapproved in the United States. 52 Since these initial
actions, the FDA implemented an Internet Drug Sales Action
Plan15 3 and continues to engage in civil1" and criminal5 .
enforcement activities. Spurred by the testimony of Dr. Woodcock
and others, the Democratic members of the House, led by
Representative Ron Klink (D-Pa.), introduced legislation to assist
in this fight.
149. See id,
150. See id.; see also Guy Gugliotta, House Votes to Put GHB On List oflllegalDrugs: Diet
Supplement Linked to Deaths, 'Date Rape', WASH. PosT, Feb. 1, 2000, at A8 (describing that,
although the FDA banned GHB in 1991, chemical precursors of GHB have been legally sold
as 'diet supplements," and indicating that this vote closed the loop hole, thus categorizing
the drug as an illegal controlled substance).
151. See Woodcock, supra note 26.
152. See id.
153. See Hubbard, supra note 115. The plan includes the following components: public
outreach, professional outreach, coordination with states and other federal agencies,
international cooperation, and refining/broadening enforcement activity. See id.
154. Most notably, after considering thousands of sites, the FDAreviewed over 400 drug-
related Internet sites for potential civil or criminal action. See id. As of May 25, 2000, the
Office of Compliance sent 38 warning letters to domestic Internet pharmacies alerting them
of potential "administrative and/or regulatory enforcement action" if the sites failed to
remedy "products, practices, processes or other activities" that the FDA considered violative
of the FD&C Act or other statute. Id. Similarly, 17 "cyber letters" (warning letters sent
online) were sent to foreign sites. See id. In addition, the FDA, working with the Department
of Justice (DOJ), obtained two preliminary injunctions prohibiting the sale of illegal items,
garnered 12 product seizures, 11 product recalls, the voluntary destruction of 18 products,
and issued 17 import alerts. See id.
155. The FDA's Office of Criminal Investigations (OCI), incooperationwithvarious federal
and state agencies, had 86 criminal investigations open and 46 preliminary investigations
occurring as of May 25, 2000. See id.
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Elevators, Escalators, and Hair Stylists
The Internet Pharmacy Consumer Protection Act (Act) was
introduced as an amendment to section 503 of the FD&C Act.15 The
Act proposes Web-based notification requirements for online
providers in an attempt to protect public health and safety,'57 and
was'prompted in part by Congressman Klink's observation that
current laws required "elevators, escalators and hair stylists... to
display more licensing information than websites selling potentially
lethal drugs."5 ' Essentially the Act has two components. The first
explains minimum identification requirements for online pharmacy
websites, 5 9 and the second addresses enforcement authority.60
Regarding identification, the Act requires the site to list the name
and state of licensure of every professional working with the site
(e.g., dispensing physicians, consulting physicians, and
pharmacists), as well as the licenses held by practitioners that
conduct patient consultations designed to provide a prescription.'
Regarding enforcement, the Act leaves the authority with the state
if the state has provisions no less stringent than those proposed in
the Act.'62 Currently, the Act remains in committee in the House.
U.S. Customs Service
The essentially exponential growth of online pharmacies in 1999
was reflected in a 450% increase in the quantity of pharmaceuticals
seized by the United States Customs Service from 1998 to 1999.'63
156. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 503 (1994).
157. See H.R. 2763, 106th Cong. (1999).
158. Klink Introduces the Internet Pharmacy Consumer Protection Act, at http'il
www.house.gov/appd/list/press/paO4..klink/pr_.990805-internet.html (Aug. 5, 1999).
159. See H.R. 2763.
160. See id.
161. See id.
162. See id.
163. In 1998, the U.S. Customs Service seized 2139 pharmaceuticals, while in 1999 the
number rose to 9725. See Prepared Testimony of Betsy Durant, Office of Trade Programs
United States Customs Service, Before the Subcomm. on Oversight and Investigations of the
House Comm. On Commerce, 106th Cong. (2000) [hereinafter Durant], available in LEXIS,
News Library, News Group File. Pharmaceutical seizures for the 2000 fiscal year appear to
be on target to meet or exceed the 1999 level. See id.
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Although this growth presents an increasing burden upon the
Customs Service's limited resources,1" the Service continues to
work separately165 and in cooperation with other federal agencies166
to limit the influx of illegal foreign pharmaceuticals. Additionally,
in testimony before Congress, the Service emphasized the need for
an approach employing cooperation, communication, and additional
resources as well the specific need for the U.S. Postal Service to
implement an automated manifest information system. 67 The
Customs Service's recommendations and actions have not been
confined, however, to domestic tactics. For example, in 1999
Customs officials worked with authorities in Thailand, a prime
source of illegal foreign drugs, to seize 2.5 million pharmaceutical
dosage units, arrest twenty-two Thai citizens,16 and demonstrate
the Customs Service's continued commitment to protect America's
borders from illegal activities, both electronic and tangible.
Department of Justice
The Department of Justice (DOJ) has also become increasingly
involved with Internet dispensing by: (1) outlining avenues that
exist for prosecuting online pharmacies through existing laws
164. The Customs Service utilizes fewer than 220 people at fourteen international mail
facilities nationwide. See i&. Although the PostalService must present all international mail
to Customs, the volume of daily shipments and the manual nature of the selection and
inspection process prevents all mail from being inspected. See id.
165. The Customs Service utilizes its CyberSmuggling Center to address the challenges
of illegal activity facilitated by electronic commerce. See id. Additionally, Customs created
a Cyber Crimes Unit to address a number ofissues including locating and identifying foreign
operators selling illegal pharmaceuticals via the Internet. See id
166. The Customs Service actively cooperates with the FDA, the DEA, and the U.S. Postal
Service via an informal working group and is involved with the FDA's Office of Criminal
Investigations on a number of continuing investigations. See i&
167. While Express Consignment Operations like FedEx and UPS must keep detailed
shipping and transaction records for Customs' examination, the Postal Service is not so
obligated and only maintains individual manifests for roughly five percent of international
mail. See id. Although the Postal Service does not possess such detailed automated
technology, it is attempting to develop a system that would provide Customs with
information comparable to that provided by Express Consignment Operators. See id.
Similarly, although Express Consignment Operators must reimburse Customs for the costs
associated with processing their packages, the Customs Service is not reimbursed by the
Postal Service for inspecting incoming foreign mail. See id.
168. See id.
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regulated by the FDA,169 the DEA, 7° and the FTC;17 1 (2) enforcing
these laws;172 (3) engaging in training and education of law
enforcement personnel;17 s (4) cooperating with domestic174 and
foreign enforcement agencies;"r' and (5) supporting the Internet
Prescription Drug Sales Act of 2000, with the proposal that the bill
be amended to provide a mechanism for injunctive relief.76
169. The DOJ identified the possibility of utilizing 21 U.S.C. § 353(b) to pursue violators
who dispense pharmaceuticals via an online questionnaire or without a prescription. See
Prepared Testimony of Ethan M. Posner, Deputy Attorney General, Before Subcomm. on
Oversight and Investigations of the House Comm. on Commerce, 106th Cong. (2000)
[hereinafter Posner, available in LEXIS, News Library, New Group File (elaborating that
§ 353(b) would consider pharmaceuticals "misbranded" if dispensed without a prescription
and highlighting that the use of a questionnaire may not meet the requirement that
prescriptions be dispensed pursuant to a valid prescription). The DOJ also noted that drugs
dispensed without a prescription and thus "misbranded" would violate 21 U.S.C. § 331(a)
when introduced or distributed into interstate commerce. See id.
170. See id. (highlighting 21 U.S.C. §§ 822, 829 and 841 because the definition of a
"prescription" under the Controlled Substances Act may not include those drugs dispensed
via an online questionnaire). A Maryland grand jury indicted a physician for dispensing
controlled substances applying these sections of the Controlled Substances Act. See id.
171. The FTC's authority to prohibit "unfair or deceptive acts or practices" could be
utilized via 15 U.S.C. § 45. See 15 U.S.C. § 45(aX1) (1994); see Posner, supra note 169. For
example, a number of online pharmacies settled charges raised by the FTC, including that
the website claimed it was a "full service clinic" and "network[ed] with an organization of
physicians throughout the United States and Internationally" when allegedly no clinic
existed and only one physician was a part of the "network." See Online Pharmacies Settle
FTC Charges, M2 PREsswIRE, July 13,2000, available in LEXIS, News Library, News Group
File; see also Posner, supra note 169 (noting the potential utility of other charges via federal
mail fraud and wire fraud theories).
172. The DOJ specifically identified ten recently filed cases ranging from charges against
a physician for dispensing controlled substances using only patients' e-mail requests to a
federal grand jury indictment against BONGMART.com for selling nitrous oxide. See id.
173. The Office of Legal Education for the DOJ presented a number ofseminars including
a how-to presentation on Internet Prescription Sales highlighting mechanisms for pros-
ecutors to investigate, analyze, and charge an online pharmacy case. See id.
174. DOJ officials have met with officials from twelve other federal and state agencies as
a member of the Drugs and Medical Products Interagency Working Group. See id.
Additionally, officials have met with various state authorities such as state medical and
pharmacy board representatives, and each state's Attorney General. See id.
175. See id. (noting U.S. support for the Council of Europe's drafting of a cybercrime
convention as well as the cooperation of the G-8 by facilitating the investigation and
prosecution of cybercrime).
176. See id.
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Presidential Proposal
The President also joined the political chorus of concern in the
final days of the last millennium by submitting a proposal to
address online pharmacies as part of the 2001 budget.177 The
Clinton proposal requires online pharmacies to obtain federal
certification through the FDA,17s and creates civil penalties of up to
$500,000 for each incident of dispensing prescription drugs without
a valid prescription.179 Additionally, the proposal grants the FDA
administrative subpoena power designed to compel cyberphar-
macies to provide records to federal officials.18 The President,
moreover, hopes to improve the FDA's ability to examine online
pharmacies by providing an additional $10 million to increase
staffing by 100 and upgrade the FDA's computer capabilities.181
In an effort to achieve these goals, the Administration, via
Secretary of Health and Human Services Donna Shalala, intro-
duced the Internet Prescription Drug Sales Act of 2000 to Congress
on May 2, 2000."8' The bill would require online pharmacies to be
licensed in each state where they practice and in each state to
which they deliver prescription drugs."a It would also mandate that
all online pharmacies meet federal laws concerning the practice of
pharmacy (i.e., storage, handling, and record-keeping requirements)
and the completion of a pre-launch notice to all applicable state
pharmacy boards, as well as the Secretary of Health and Human
177. See Statement Announcing Zero Tolerance for Prescription Drug Internet Sites
Harmful to Patient Safety and Health, 35 WEEKLYCOMP. PRES. DOC. 2677-78 (Dec. 28,1999);
Checklist of White House Press Releases, 35 WEEKLY COMP. PRES. DOC. 2680 (Dec. 27-8,
1999); Robert Pear, Controls Sought for Drug Sales On the Internet, N.Y. TIMES, Dec. 28,
1999, atAl; The ClintonAdministration UnveilsNew Initiative to Protect Consumers Buying
Prescription Drug Products Over the Internet [hereinafterNew Initiative], The White House
Office of the Press Secretary, at httpwww.whitehouse.gov/WH/New/html/19991229.html
(Dec. 28, 1999).
178. See New Initiative, supra note 177 (specifying that "[s]ites operating without first
demonstrating FDA compliance twill] be subject to sanctionsi); Pear, supra note 177.
179. See New Initiative, supra 177.
180. See i&L
181. See id.; Pear, supra note 177.
182. See Hubbard, supra note 115.
183. See id.
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Services.' 'Finally, the bill would provide both federal and state
mechanisms for enforcement, including monetary civil penalties."8 5
The proposal, in general, and the bill, in particular, represent a
reversal of the Administration's views on online pharmacy
regulation.186 While the Administration may believe that Congress
is willing to progress in this area,' given its introduction of the
Internet Pharmacy Consumer Protection Act,' 8 such optimism may
be misplaced.'89
The presidential proposal has drawn limited, essentially
courteous, approval from pharmacy professionals, who compli-
mented the President for recognizing the benefits of online
pharmacies as well as the need for strong penalties for rogue
operators.'O Professional organizations, however, have voiced
opposition to a proposal that expands FDA authority over online
pharmacies. 191 The reputable pharmaceutical players in this market
prefer that the regulatory power remain where it has always
existed, with the states.19 Meanwhile, as the President and
Congress prepared to battle illegitimate online pharmacy services
184. Specifically, the notice would need to contain "information required to be posted on
the site and assurances of compliance with the requirements of the bill." Id The bill would
also call for the posting of a declaration on the website confirming compliance with the notice
requirement and providing information that could be used to contact the pharmacy (i.e., the
address and phone number of the pharmacy). See id.
185. The Secretary could prevent the site from posting its declaration of compliance after
proper notice and opportunity provisions were met. See iU Sites that violated the proposed
Act could incur fines and be the subject of state civil action. See id
186. ClintonProposes GreaterFDAAuthority OverOnlinePharmacies;Reactions Skeptical
[hereinafter Clinton], BNA HEALTH L. REP. Jan. 6,2000, at 12, available in LEXIS, Area of
Law-By Topic, Healthcare & Medical (noting that only a few months earlier, Justice
Department Deputy Associate Attorney General Ivan Fong told the House Commerce
Subcommittee on Oversight and Investigations that "more assistance for enforcement [was
needed], not more laws").
187. See id.
188. H.R. 2763, 106th Cong. (1999).
189. A spokesman for House Commerce Committee Chairman Thomas Bliley, Jr. (R-Va.)
indicated that the Chairman is concerned that such a proposal would be "a precedent for
regulation of the Internet by politicians who not only do not understand the technology, but
could not turn on a fax machine." Clinton, supra note 186.
190. See id.
191. Both the National Association of Chain Drugstores and the National Association of
Boards of Pharmacy have indicated their disapproval of measures that would expand FDA
authority. See id.
192. See id.
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with the pen and the purse, states' Attorneys General began
combating these practices with laws already on the books.
Consumer Protection through Existing State Laws
Although states lacked any explicit laws relating to online
prescribing, 9 ' they challenged pharmacies and providers with
existing licensing and consumer protection regulations.' 94 Missouri
Attorney General Jay Nixon provides a classic example. He
obtained a temporary restraining order.9 . (TRO) followed by a
permanent injunction 96 against S&H Drug Mart, which uses the
website www.ThePillbox.com, and William Stallknecht, its phar-
macist-owner. Both were featured in a New York Times special
report.' The basis for the claim was that the San Antonio
pharmacy was providing medications to Missouri citizens without
a Missouri pharmacy license.' 9 The final order required that: (1)
Stallknecht pay restitution to Missouri residents who made online
193. See Smoak, supra note 77.
194. In addition to actions in Missouri and Kansas, state law enforcement officials have
also launched offensives against online pharmacies and providers in Arizona, Florida,
Illinois, Michigan, New Jersey, and Pennsylvania. See Online Pharmacies Charged with
Consumer Protection Law Violations, BNAHEALTH L. REP. May 11, 2000, at 693 (explaining
three suits in Pennsylvania involving violations of consumer protection laws by online
pharmacies); State Files Consumer Fraud Charges Against Eight Online Pharmacies, BNA
HEALTH L. REP., Apr. 6, 2000, at 503 (discussing New Jersey's efforts against illegitimate
online pharmacies); State Files Consumer Fraud Lawsuit Against Online Pharmacy,
Pharmacist, BNA HEALTH L. REP., July 20, 2000, at 1123 (describing two suits filed by the
Arizona Attorney General's office); State Officials Form Internet Prescription Task Force to
Review Current Laws, Security, BNA HEALTH L. REP., Jan. 20, 2000, at 92 (depicting the
agreement often companies not to sell prescription pharmaceuticals to Michigan residents
after Michigan's Attorney General threatened to sue); Sara Fritz, In U.S., No Easy Ex For
Online Pharmacies, ST. PETERSBURG TIMES, Apr. 2, 2000, at 1A, available in 2000 WL
5605608 (indicating that, to date, Florida had only pursued one online pharmacy); On-Line
Pharmacies: Illinois Sues Four Cos. For Fraud, AM. HEALTH LINE, Oct. 22, 1999, available
in LEXIS, News Library, Medical and Health Materials; infra notes 195-207 and
accompanying text.
195. See Nixon Obtains TRO to Stop Illegal Internet Sales of Drugs [hereinafter Nixon],
at httpd/www.ago.state.mo.us/7899.htm (July 8, 1999).
196. See Missouri Judge Blocks Internet Drug Sales by Texas Pharmacy Unlicensed in
State [hereinafterMissouri Judge], BNA HEALTH L. REP. Oct. 28,1999, at 1721, available in
LEXIS, Area of Law-By Topic, Health:are & Medical.
197. See Stolberg, supra note 7.
198. See Nixon, supra note 195.
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purchases from January 1 to June 30, 1999; (2) Stallknecht "pay
$15,000 in penalties and costs to the state of Missouri;" (3) the
website post a notice that prescription sales were not available to
Missouri residents; and (4) violations of the injunction would result
in a maximum penalty of $5,000.199 The claim was brought after two
prescriptions were filled without verification during an
investigation by the Attorney General's office.20 Although William
Stallknecht, the pharmacist-owner of ThePillbox.com, indicated
that he keeps detailed records and dispenses only prescriptions of
Texas physicians to reduce potential suspicion in other states, he
admitted his daily expectation that investigators will arrive at his
store.0 1 In conjunction with the TRO, Nixon obtained an agreement
with the Texas physician who wrote the unverified prescription that
he would no longer treat Missourians or provide prescriptions for
them using Internet services. Under similar circumstances, Nixon
obtained a TRO against a Houston clinic, pharmacy, and
physician.0 3
Meanwhile, in Kansas, State Attorney General Carla Stoval filed
a similar claim for offering medications without adequate patient
evaluation and deceptive advertising,20' as well as five consumer
protection suits20 5 against numerous companies, pharmacies,
physicians, and other individuals. Stovalls claims arose initially
199. Missouri Judge, supra note 196.
200. One prescription was for Propecia and was ordered by a pregnant investigator after
providing a false name. See id.
201. See Stolberg, supra note 7.
202. See Nixon, supra note 195.
203. See Nixon Obtains TRO Against Online Clinic and Pharmacy to Stop Illegal Internet
Prescribing and Sales of Drugs, at httpj/www.ago.state.mo.us/82699.htm (Aug. 26, 1999).
204. See Attorney General Stovall and Kansas Board of Pharmacy File Lawsuit Against
Company Selling Viagra on the Internet [hereinafter Attorney General], at
http/www.ink/orgpubli/ksagcontentsnews-releases/news99/viagra.htm (Feb. 25, 1999).
205. See Attorney General Files Lawsuits to Prohibit Internet Drug Sales, at http'll
www.ink.org/public/ksag/contents/news-releases/news99intemetdrugsales.htm> (June 9,
1999) (describing three instances in which a minor, working with investigators, purchased
Viagra and Meridia, a controlled substance, without an exam or consultation, usinghis real
age and mother's credit card). Attorney General Stovall reached a settlement in one case,
was requesting the court to enforce a settlement in a second case, and was negotiating
settlements in the remainder of cases pending as of May 25, 2000. See Hearings Before the
Subcomm. on Oversight and Investigations of the House Comm., 106th Cong. (2000)
(statement of Carla J. Stovall, Kansas Attorney General[ hereinafter Stovall], available in
2000 WL 726296.
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from a suit filed by her office in November of 1998, on behalf of the
Kansas Board of Pharmacy, against Dr. Leandro Pasos for
violations of the Kansas Healing Arts Act.2"6 Foreshadowing
potential future problems for regulators, the Washington Medical
Quality Assurance Commission cited Dr. Pasos for unprofessional
conduct as a result of his online prescribing roughly six months
after the Kansas Board named him in a suit.
20 7
In an effort to reduce such duplicative efforts, conserve resources,
and promote effective law enforcement, the National Association of
Attorneys General (NAAG) created an Online Pharmacy Working
Group.0 ' Although this collaborative effort has already demon-
strated its utility,2 9 State Attorneys General recognize that a
successful approach will require federal cooperation. To that end,
the NAAG adopted a resolution endorsing "cooperative federalism
in addressing Internet issues."210 More importantly, the NAAG set
forth two concrete requests:. First, that the states remain the
"primary enforcers oflaws relating to the health of their citizens;"2
and second, that the federal government provide "nationwide
injunctive relief."2" In doing so, the states actively defined their
preferred role in this arena and offered a tangible example of how
to reach this objective. Such suggestions, however, are not
exhaustive. For example, as existing state laws have provided some
recourse for authorities, a few states have begun a more targeted
approach.
Creating New State Laws
In an effort to address some of the jurisdictional complications of
online dispensing, one of the first of a new breed of laws addressing
206. KAN. STAT. ANN. §§ 65-2801 to -2890 (1993 & Supp. 1999); Attorney General, supra
note 204.
207. See Stolberg, supra note 7.
208. See Stovall, supra note 205.
209. See id. (elaborating on the effective collaboration of Kansas and Washington against
an online pharmacy and physician).
210. Id.
211. Id.
212. Id The NAAG foresees a law similar to a federal telemarketing law permitting
"Is]tates to obtain an injunction effective nationwide, and yet not prohibit any State from
filing an action in its State court, based on State law." Id.
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nonresident Internet pharmacies was passed in Indiana.1
Indiana's Internet pharmacy law requires providers to adhere to
Indiana's generic drug laws as well as the law of their domicile.1 4
Similarly, Arkansas modified and expanded its existing nonresident
pharmacy statute to address the growing concerns of Internet
pharmacies. The law requires the out-of-state pharmacy to be
licensed in Arkansas, to have a licensed Arkansas pharmacist, and
to designate an Arkansas resident as an agent.1 5 In addition, if the
pharmacy comes under scrutiny, it must appear before the
Arkansas Board of Pharmacy.21 6
In a related effort, Illinois legislators have required nonresident
pharmacies to meet special registration requirements. 7 Finally, a
number of other states are reviewing potential legislative options
to address the complexities of online dispensing.21 8 While states
have begun enforcing existing laws and developing new laws, State
Medical and Pharmacy Licensing Boards have been active partners
in the enforcement of acceptable professional practice standards.
Licensing Boards
With the primary objective of upholding the standards of
professional practice, and perhaps the secondary motive of instilling
in offenders the fear of prosecution, suspended licenses, and the
inability to practice, state licensors have stepped in. For example,
the Illinois Professional Regulation Department suspended the
license ofDr. Robert Filice for writing Viagra prescriptions founded
213. See IND. CODE ANN. §§ 25-26-18-1, -2 (Michie Supp. 2000); Nancy Tarleton Landis,
Virtual Pharmacies Boast EasyAccess, Privacy Safeguards 56 AM.J. HEALTH-SYS. PHAR ACY
1174,1174(1999).
214. See IND. CODE ANN. § 25-26-18-2 (Michie Supp. 2000); Landis, supra note 213, at
1174.
215. See ARK. CODEANN. § 17-92-401 (Michie 1995 & Supp. 1999); Landis, supra note 213,
at 1174.
216. See ARK. CODE ANN. § 17-92-401 (Michie 1995 & Supp. 1999).
217. See Landis, supra note 213, at 1174.
218. Legislation focusing on online pharmacies is pending in California, Kansas, Maine,
New Hampshire, New York, and Rhode Island. See Chad Bowman, More Regulators Just Say
No To Online Drug Prescriptions, BNA HEALTH L. REP. May 18, 2000, at 729, available in
LEXIS, Area of Law-By Topic, Healthcare & Medical. Similarly, Virginia instituted an
evaluation of online pharmacy dispensing. See id.
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only on the information contained in a single page patient
questionnaire and payment of an $85 consulting fee.219 His license
was later reinstated with restrictions following a hearing.2
Similarly, eleven other state medical boards have acted against
physicians for writing online prescriptions. 22' A Nevada physician
was warned that he could no longer continue online prescribing
with Viagra. 222 In Wisconsin, the board "summarily suspended" a
physician, only to later reconsider the decision.2" In Colorado, the
board chided a physician and warned of the future potential for
disciplinary action.2 4 These actions have been welcomed by
national professional organizations that possess the ability to make
and recommend standards, as well as guide practitioners, but are
limited in their authority to reprimand.
Professional Organizations
The AMA has expressed its almost sacred consideration for the
physician-patient relationship and its concern at the potential for
significant erosion of that relationship through improper,
unregulated online prescribing.2 25 The organization has made it
clear that the requirements 26 a physician must satisfy to establish
a physician-patient relationship in a traditional setting should
apply equally to the Internet.227 As such, prescriptions offered
"solely on the basis of a questionnaire would not suffice,"228 and
219. See Abromowitz, supra note 49; John Chase, Doctor in On-line Viagra Case Closes
Office, CHl. TRIB., May 7, 1999, at 7, available in 2000 WL 2870995.
220. See Abromowitz, supra note 49.
221. See Bowman, supra note 218 (including California, Colorado, Florida, Hawaii,
Michigan, Missouri, Nevada, Ohio, Washington, Wisconsin, and Wyoming). A minimum of
eight additional medical boards have released statements concerning online prescribing. See
iL
222. See CherylA. Thompson,Internet-basedPrescribingandDispensing TroubleMedical
and Pharmacy Boards, 56 AM. J. HEALTH-SYs. PHARMAY 500,500 (1999).
223. See id.
224. See id.
225. See Abromowitz, supra note 49 (expressing the AMA's "graveD concerng about
current misuse of the Internet for prescribing purposes").
226. See supra note 144 and accompanying text.
227. See Smoak, supra note 77.
228. Id.
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"fallD well below a minimum standard of medical care."229 The
AMA, however, has indicated its concern for the simultaneous
protection and development of legitimate electronic prescribing
opportunities.280 Promoting the optimal use of this developing
technology while inhibiting its abuse is a delicate balance. To that
end, the AMA Board of Trustees has recommended a six-point plan
concerning its professional role in guiding the use of online
prescribing and its cooperation with other organizations in
cyberspace.23 '
The AMA's first three recommendations express its opposition to
online prescribing without adequate protections, its desire that
state licensing boards act against improperly operating sites as well
as practitioners, and its proposal that the AMA develop guidelines
on the physician-patient relationship given the advancements in
technology.2 2 The remaining three of the AMA's six recom-
mendations deal with its cooperation with other organizations, the
first being the FSMB.233 In this cooperative effort the AMA hopes to
develop model laws on Internet prescribing at the state level.2'
The second collaborative partner identified by the AMA is the
NABP.23 5 In particular, the AMA indicated its support of the
NABP's Verified Internet Pharmacy Practice Sites (VIPPS)
program. 2 6 The NABP developed the program to address growing
public concern about Internet pharmacy services,23 7 and the AMA
supports the program because it provides a mechanism whereby
"physicians and patients can easily identify legitimate Internet
229. Id.
230. See supra note 146 and accompanying text.
231. See Smoak, supra note 77.
232. See id.
233. See id.
234. The concerns of the AMA and the Federation of State Medical Boards on the subject
seem well matched. In a February 1999 FDA meeting, thet FSMB stressed the use of a
collaborative approach and professional leadership. See Minutes, supra note 100. The FSMB
Committee on Professional Conduct and Ethics has also noted, -'it would be unprofessional
to issue a prescription or a recommendation to a patient without conducting an evaluation
adequate enough to establish a diagnosis.'" Rubin, supra note 110 (quoting James Winn,
Executive Vice President of FSMB).
235. See Smoak, supra note 77.
236. See id.
237. See National Ass'n of Bds. of Pharmacy, VIPPS Home Page, at http:/www.nabp.
nettvipps/intro.asp (last modified Oct. 7, 1999).
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pharmacy practice sites."25 The program requires VIPPS certified
pharmacies to adhere to the "licensing and inspection requirements
of their state and each state to which they dispense." 9 The first
certified pharmacies, Drugstore.corn, Merck-Medco Managed Care
L.L.C., and planetRx.com, bear the VIPPS certification hyperlink
signifying that they meet the twenty-point pharmacy practice
criteria.' Finally, the AMA also proposed working with the FDA
and other regulatory agencies to eliminate illegally operating online
pharmacies.2 1
WHOSE JOB IS IT ANYWAY?
FDA Authority
Certification
The FDA has deftly pursued violators and should be commended
for its efforts. The FDA's initial intention to follow the Framework
for Global Electronic Commerce, proposing that the private sector
should lead along with the states is especially commendable. 2
President Clinton's proposal to expand FDA authority, however, is
troubling. The proposed federal certification will yield limited
efficacy. Although federal certification may provide the FDA with
a master list of online operators and consumers with additional
information about their online provider, it seems likely that the
predominant registrants will be reputable operators. Some rogue
sites may shy away from the arena if the proposed stiff penalty for
lack of certification is enforced, but many will likely continue to
operate illicitly, moving from state to state until the states
238. Smoak, supra note 77.
239. National Ass'n of Bds. of Pharmacy, supra note 237.
240. See National Ass'n of Bds. of Pharmacy, VIPPS Criteria, at httpi/lwww.nabp.
netlvipps/consumer/criteria.asp (last modified Nov. 29, 1999). Since these first three sites
were approved, the following sites also have received the VIPPS seal of approval: cvs.com,
familymeds.com, healthscript.com, teldrug.com, eMD.com, accuratepharmacy.com, and
clickpharmacy.com See National Ass'n of Bds. of Pharmacy, List of Pharmacies, at
httpJ/www.nabp.netvippslconsumer/listall.asp (last visited Oct. 23, 2000); National Ass'n
of Bds. of Pharmacy, What's New, at http'/www.nabp.net (last visited Oct. 23, 2000).
241. See Smoak, supra note 77.
242. See Woodcock, supra note 26.
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themselves have adopted sufficient, effective regulatory and
enforcement mechanisms.
Certification will devastatingly blur the boundary between the
states' and federal government's authority to regulate pharmacy
practice. Mandatory federal certification would enable the federal
government to regulate electronic pharmacies such as Eckerd
online, but the FDA would continue to lack any authority to
regulate traditional brick and mortar pharmacies such as a
neighborhood Eckerd store. Consider those pharmacies, both large
retail chains and local independents, that permit patients to
electronically request their prescriptions and then to pick up the
prescriptions at their neighborhood pharmacy. Would the electronic
transmission of a prescription or refill request convert the tra-
ditional pharmacy into an online pharmacy subject to federal
oversight?2' Where will the FDA's authority cease and the states'
authority begin?' Would such access then compel the need for
brick and mortar access? The prospect of federal certification seems
to generate more questions than it answers, possibly explaining
why online pharmacy providers have expressed concern over the
appropriateness and effectiveness of such a system. 5 As a result,
certification may unnecessarily restrict the electronic options that
pharmacies offer their patients and essentially inhibit a core tenet
of the Internet-access. It is likely that such an outcome would
most significantly impact independent pharmacies, perhaps driving
them out of pharmaceutical e-commerce and eliminating a valuable
tool for competing with the mammoth chains.
243. If answered affirmatively, the FDA would go from having no authority to regulate
pharmacies to having the authority to regulate both online and traditional sites. If answered
negatively, regulators could not effectively monitor the entire prescriptive process at a
federal level. Would this compel the need for brick and mortar access? If the FDA is being
stopped at the pharmacy's front door, would the agency examine alternative ways to get
behind the pharmacy counter, perhaps entering through the telephone lines?
244. Consider patients that use the Internet sometimes and brick and mortar pharmacies
at other times. Will this allow the government access to each brick and mortar pharmacy
where the patient has received a prescription and also used online services? What about
patients who simplyhave a question answered online but have all of their prescriptions filled
nonelectronically?
245. As one online pharmacy CEO stated, the proposed FDA subpoena authority and
accompanying legislation "must be narrowly tailored... to avoid creating problems for the
legitimate online pharmacies." Clinton, supra note 186.
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Penalties
Although the certification system appears problematic, the need
for increased penalties associated with violations is obvious.
Without severe and enforceable penalties, there will be little
incentive for operators to follow the law or officials to enforce the
law. Current federal law makes the dispensing of a prescription
medication without a valid prescription illegal.' Such existing
laws, as identified by the DOJ, 47 could be expanded monetarily,
and legislative terms could be modified to define online prescribing
effectuated via a short questionnaire as failing to meet the
definition of a valid prescription. As such, individual prescribers or
websites could be held responsible for such actions. Although
effective enforcement of such penalties may depend on the
assistance of state regulators, the FDA could likely enact such
penalties without the kind of drastic expansion of authority
inherent in online certification.
Administrative Subpoena Power
The Administration's proposal fails to address the limits of the,
Administration's new-found subpoena power. In particular, various
potential patient privacy concerns arise. Once again, the concept
generates a multitude of questions. How would such power be
brought to bear in the case of a provider that offers only online
services or the potentially more problematic situation in which a
consumer uses both online and traditional components of his
pharmacy? Will the FDA be sending investigators to the corner
drugstore to obtain the files they desire? Will these investigators be
privy to confidential patient information? To what extent will the
FDA seek to prosecute individuals receiving dangerous or
unapproved agents as opposed to the websites offering such
products? Health care providers, pharmacists especially, are faced
with numerous existing barriers to effective patient communi-
246. See 21 U.S.C. § 353(b) (1994 & Supp. 1I 1997).
247. See supra notes 169-76 and accompanying text.
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cation.24 s Such power may potentially inhibit patients' willingness
to address openly their medication concerns and may dangerously
inhibit daily provision of effective pharmaceutical care.249
Foreign Sites
Regulating the electronic border-crossing of foreign sites into the
United States admittedly may be the most problematic aspect of
online pharmacies. The absence of any suggestions within the
President's proposal, however, represents a lost opportunity to
introduce a comprehensive plan. The inherent limits of federal
authority to penalize foreign online pharmacies from offering
products in the United States significantly limit regulators' options.
Given the FDA's national authority to approve pharmaceutical
agents for sale in the United States, as well as its international
reputation, the FDA is most suitably positioned to address the
global market. Consequently, it would provide a unified national
voice to foreign online pharmacies, Internet service providers, and
governments. The agency's electronic warnings to foreign
cyberpharmacies are a valuable first step.250 Similarly, the
formation of a comprehensive Internet Drug Sales Action Plan251
and a desire to maintain existing relationships with foreign
agencies 211 should be applauded.
A laudable goal would be the creation of an international panel
coordinated under the auspices of the WHO. The panel could be
established to develop uniform mechanisms for nations to inform
one another of rogue sites operating within their borders and
248. Such barriers include high pharmacy counters creating an actual obstruction between
pharmacists and patients, noisy practice environments (i.e., constantly ringing phones), lack
of a private consultation area, and reduced time to spend with patients due to excessive
dispensing demands.
249. This may be especially true ifpatients perceive FDA oversight as a potential limit on
their use of nontraditional products, such as herbal agents, which have experienced a recent
surge in popularity. Patients may be more apt to forego consultation with the pharmacist,
risking potentially life-threatening drug interactions or disease contraindications.
250. See FDA Launches 'Cyber" Letters Against Potentially Illegal, Foreign-Based Online
Drug Sites, at httpJ/www.fda.gov/bbstopics/ANSWERSANS01001.html (Feb. 2, 2000).
251. See supra note 153 and accompanying text.
252. See supra note 118 and accompanying text.
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outline a series of steps for dealing with such providers.2 3 As with
existing efforts, the FDA could participate in such an effort through
its OC. Similarly, professional organizations with an international
membership, such as the NABP, could assist in bridging these
regulatory gaps by expanding professional guidelines and
commenting upon proposed enforcement or legislative actions.25'
FDA as a Centralized Resource
The administration's proposal is not entirely flawed. The FDA
may serve as an exceptionally useful centralized resource for the
states, and the President's proposal to increase funding to assist the
FDA in countering rogue online pharmacies is an excellent step in
the right direction. Additionally, the measures taken to educate
consumers and practitioners through the FDA's new website255 and
the intended "Potentials & Perils" campaign25 are also meritorious.
The FDA should continue to search, investigate, and prosecute
online pharmacy offenders, using its OI as a key player in this
process. Similarly, the Administration should be encouraged to
retain its active links with other agencies (foreign and domestic),
professional organizations, and practitioners to remain abreast of
pharmacologic trends and technologic developments within the
online pharmacy arena. For instance, the laudable efforts of the
U.S. Customs Service and DOJ dovetail nicely with the FDA's
approach. Their separate and collaborative efforts should continue
to advance. Also, the FDA may be uniquely situated to function as
253. Such steps could include notifying the foreign online pharmacy of its alleged
infraction, and then sending a copy of the notification to the foreign nation's representative,
and a representative of the ISP. If the pharmacy failed to remedy the situation in a certain
period of time, the host nation could impose a standard sanction (e.g., minimum fine) and,
perhaps by predetermined agreement with the ISP provider, terminate service to the
offending site.
254. See Hearings Before the Senate Comm. on Health, Education, Labor and Pensions,
106th Cong. (2000) (statement of Carmen A. Catizone, M.S., R.Ph., Executive
Director/Secretary, NationalAssociation ofBoards of Pharmacy), available in LEXIS, Federal
Legal-U.S., Individual Legal News, FederalNews Service (Mar. 21,2000) (statingthat NABP
members include "state boards of pharmacy in all [U.S.] jurisdictions ... the Virgin Islands,
Puerto Rico, Guam, nine provinces of Canada, three Australian states, and New Zealand").
255. See Buying Medical Products Online, http'/Aww.fda.gov/oc/buyonline/default.htm
(last visited Oct. 23, 2000).
256. See Clinton, supra note 186.
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a national clearinghouse of information from the states regarding
offenders.
Some states are implementing online lists of health care
professionals that have been subject to discipline to provide
consumers with greater information regarding the practitioner they
select.257 Similarly, the FDA could receive and publish on its
website a master list of those sites that the states have reported as
violating state provisions. Alternatively, if the states independently
developed such sites, the FDA could create a master site with links
to each of the state sites.
The FDA should also be encouraged to establish partnerships
with private and academic sectors to increase its breadth of
available technological resources.
Legislative Responsibilities and the Internet Pharmacy Consumer
Protection Act
The Internet Pharmacy Consumer Protection Act (Act) has been
called a "first step" by one of its developers, and it appears to be a
good one.25 By providing minimum standards for identification of
Internet pharmacy providers and then leaving the enforcement of
the issue to the states, Congress has demonstrated an appropriate
balance for the regulation. The Act suffers, however, from some of
the same deficiencies found in the Administration's proposal
because, with minimum identification standards, like mandatory
certification, an assumption is made that providers will comply.
Again, the reputable sites likely will comply; given the ability of
providers to hide in cyberspace, however, it will be extremely
difficult to identify and enforce penalties against those who do not.
If sites do not comply, how can they be identified? Unfortunately,
neither the President's proposal nor the Act under review addresses
this issue.
257. See Jeff Houck, Web Site Puts Patients On Line to Probe Doctor Lawsuits, PALU1
BEACH POST, July 16, 1999, at 1B, available in 1999 WL 21272140 (describing Florida's
Department of Health website that provides information on doctors' academic credentials,
state disciplinary actions, and malpractice judgments over $5,000).
258. See Ron Kink, Safety System Challenged By Drug Sales on Internet, available in
LEXIS, News Library, Roll Call File (Feb. 21, 2000).
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Congress may fulfill its legislative responsibility by first doing its
best to provide additional funding for the FDA, as requested by the
President, and for other collaborating agencies in need of additional
resources such as the U.S. Customs Service. The legislators may
also promote the development of advanced technologies to assist the
FDA and the states in their identification and enforcement efforts.
This might be accomplished by establishing federally funded
research grants targeted at the academic sector, or tax incentives
for private companies to develop more advanced Web searching
technology. While creating such incentives, legislators must also be
mindful of the desire not to inhibit unreasonably online commerce
and communication.
The States
The predominant state laws that exist to counter the current
situation are clearly inadequate.259 States' Attorneys General are
forced to tackle twenty-first-century problems with twentieth-
century laws designed without adequate consideration for the
Internet. These provisions are ineffective deterrents because they
lack significant penalties.26 Additionally, the nature of the Internet
makes it relatively easy for offenders to jump from one state to
another state where policing may be less rigorous, or where the
laws are even less useful to prosecutors. Even with these
difficulties, a number of diligent States' Attorneys General pursued
commendable and successful claims against rogue operators in
1999.261 Amidst the morass of inadequate traditional laws, a few
state legislatures have been successful in developing new laws in an
attempt to deal with this problem.262 In doing so, they have begun
to forge a new legislative path for dealing with these sites.
These new state laws may represent one of the best future tools
because of their focused approach and consideration of developing
259. This inadequacy is exemplified by the fact that nineteen states will likely evaluate
bills dealing with the regulation of online pharmacies next year. See Clinton, supra note 186.
260. See Pear, supra note 177 (describing federal officials frustration that most fines were
limited to $1000 for a violation).
261. See supra notes 195-207 and accompanying text.
262. See supra notes 213-18 and accompanying text.
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technology. The success of such laws, however, depends on the co-
existence of stringent penalties, effective tools for identification,
and diligent enforcement. All of these elements must be supported
by a foundation of cooperation among the states, between the states
and federal government, and between the states and professional
organizations. The NAAG's suggestion of nationwide injunctive
relief in the exercise of "cooperative federalism" is a sensible
example of how this spirit of cooperation may enhance regulatory
efforts and should be implemented.
Professional Organizations
To date, professional organizations have adequately fulfilled their
advisory duties by providing information and guidance to
government regulators. In order to realize their potential, these
organizations must fulfill their developing commitments to produce
revised practice standards for their practitioners. Organizations
such as the AMA and NABP serve a crucial link between
government regulators and the professionals they represent,
because such organizations generally have a more accurate
knowledge of their constituents' concerns and capabilities, making
them well suited to tailor narrow but effective revised practice
standards. It seems innately more likely that professionals will
prefer regulations generated from associations or organizations
within which they have a stake than from the federal or state
government. Alternatively, it also seems more likely that effective,
appropriately tailored state and federal regulations will result from
a cooperative effort between the government and professional
organizations. Although plans are being made in this regard,2" such
standards have yet to be introduced. Professional organizations also
have the ability to make significant contributions in an advisory
capacity to the state and federal government concerning proposed
legislation. Essential to the effectiveness of these standards will be
their association with well-defined and enforced penalties for
violations. Additionally, the development and introduction of the
VIPPS Certification Program by the NABP is a premier example of
263. See Abromowitz, supra note 49; Smoak, supra note 77; Stovall, supra note 205.
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the type of forward-thinking, precisely defined tool that will benefit
both practitioners and patients. Although the program has been
criticized for being voluntary, and as such will likely fail to motivate
rogue operators to meet its standards, it is precisely this type of
professional leadership that the FDA depended upon when
affirming the Framework Global Electronic Commerce. Because a
program of this type is voluntary, it will provide added incentive for
reputable providers to meet its rigid standards in order to market
themselves as a leader in the field.
Finally, for programs such as VIPPS and revised practice
guidelines to be effective, an educational campaign must accompany
such efforts. The campaign should be two-pronged, targeting both
professionals and the public. After updating professionals'
knowledge of the field, these newly educated professionals may then
help directly educate their own patients. In this manner the
professionals may help reinforce the public messages conveyed via
professional organizations' websites and traditional advertising.
These organizations may seek to enlist student members of their
respective bodies to assist in this public outreach.
CONCLUSION
The initial shockwave that followed the cyberpharmacy explosion
left unsuspecting regulators dazed. As the dust begins to clear, it
appears that the states, partnered with professional organizations
and the federal government, are best positioned to address the
unique issues associated with electronic pharmacies on the front
line. Although apparently no more prepared than any of their
regulatory counterparts, the states' historic function as regulators
of pharmaceutical dispensing and licensure in the traditional (Pre-
E) sense, has enabled them to regain their legislative and
prosecutorial footing and establish a presence in this emerging
electronic health care environment. The states, however, cannot
police this arena alone. The inherent jurisdictional complexities
require significant cooperation to adequately prohibit, identify, and
prosecute offenders. With this in mind, a comprehensive
mechanism is necessary. An approach that includes revised practice
standards, Internet-focused state promulgated regulations, stiffer
617
WILLIAM AND MARY LAW REVIEW
penalties for violators, and enhanced identification tools is
essential. The utilization of the FDA as a centralized tracking and
enforcement resource at home and as a unified voice of authority to
deal with foreign violators, coupled with the education of
professionals and the public will also be crucial. In this respect, the
FDA's initial efforts, via its Internet Drug Sales Action Plan, appear
well targeted. Similarly, the continued attention, innovation,
collaboration, and labor of professional organizations and other
federal agencies are necessary. The implementation of such an
organizationally broad, but narrowly focused, approach will enable
the government to develop guidelines that protect the safety of U.S.
citizens, while having the least restrictive impact on Internet
commerce and the exchange of information.
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